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1.1. Characteristics of Fluorescence Spectra of Lanthanide 
Fluorometry is a very useful tool in a variety of analytical regions since it can provide 
high sensitivity, good selectivity and multiparameter information, such as fluorescence 
intensity, lifetime, anisotropy and others. It has been widely applied in biomedical research 
and clinical diagnosis [1, 2], such as in astrospace living and environmental monitoring, 
interaction mechanisms of molecules, immunoassay, DNA sequencing, fluorescence in situ 
hybridization, and in cellular imaging. Developing new fluorescent reagents and analytical 
methods is one of main research directions for improving sensitivity and selectivity of 
bioanalysis. Lanthanide complexes have become a particularly attractive focus because of the 
specific features of their fluorescence. 
1.1.1. Fluorescence Emission Mechanism of Lanthanide Complexes 
Fluorescence [3, 4] of conventional fluorophores is the result of several processes as 
shown in the left of Fig. 1.1 (Jablonski diagram). In the excitation stage, the fluorophore 
absorbs energy supplied by an external radiation and is raised to any one of the vibrational 
multiplets of the first excited singlet state (S1) from ground state (S0). Most of the 
fluorophores in the S1 state rapidly relax, through internal conversion (non-radiative decay), 
to the lowest vibrational level S1, in which fluorescence emission originates. A photon is 
emitted on returning to the ground state (S0). Other processes such as collisional quenching, 
energy transfer and solvent interactions may also occur. They are non-radiative decay. 
Conversion from S1 to the first triplet state T1 is intersystem crossing and transition from T1 to 
ground state is forbidden, so its decay rate is slow, yields phosphorescence. 
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Figure 1.1. Fluorescence emission mechanism of Eu3+ complex. 
S0, S1 and T1 are singlet ground state, singlet excited state, and triplet state, respectively. 
 
There are 15 elements in the lanthanide series, but only Sm3+, Eu3+, Tb3+ and Dy3+ 
enabling fluorescence. However, the absorption and fluorescence of these ions are very low 
and difficult to be used in analysis. They usually need to ligate an organic compound as 
antenna for energy transfer to metal ions. 
The fluorescence emission process of lanthanide complex [5, 6, 7] (in Fig. 1.1) is of 
some particularities that is absent in conventional fluorophores: (a) The ligand, not the 
lanthanide ion itself, absorbs energy from external source into S1 from its S0, then proceeds on 
the internal conversion. b) That intersystem crossing to T1 from the lowest vibrational level S1 
can further proceed to intramolecular energy transfer from T1 of the ligand to the localized 
appropriate 4f energy level of the central lanthanide ion, which in turn can moves up to its 
Chapter 1. Introduction 
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own excited singlet state. It requires that deactivating ligand transition (S1 ? S0 and T1 ? S0 ) 
must be minimal and the energy level of ligand T1 should be matched, namely close to, but 
just higher than the resonance level of lanthanide ion. c) The multiple emissions. For example 
in the europium complex, multiple emissions [8] are observed as several electronic transitions 
5D0 ? 7FJ (J = 0, 1, 2, 3, 4) and 5D1 ? 7FJ (J = 1, 2, 3, 5, 6), the most intense transitions are 
5D0 ? 7F2, and 5D0 ? 7F1 with emissions around 610-660 nm and 585-600 nm. 
The above mechanism results in the three main advantages of lanthanide complexes in 
fluorometry. First is the large Stokes´ shift (150 – 300 nm). Owing to energy dissipation 
during internal conversion, intersystem crossing, and intramolecular energy transfer, energy 
of photon emitted from lanthanide complexes is significantly different from that of the 
excitation radiation, and therefore the Stokes´ shift of lanthanide complexes is usually large. 
This feature can be applied to avoid the overlap between excitation and emission spectra of 
fluorophore itself (inner filter effect) or emission from biological matrix. 
Second is the narrow emission bands (1 – 20 nm), namely line-like bands. It is because 
of the shielding of the f orbitals by the higher s and p orbitals of lanthanide. It is noted that 
there are three and five components of the emission splitting patterns [9, 10] from 5D0 ? 7F1 
and 7F2, for example in Eu3+ complexes. But the failure to observe such splitting may be due 
to spectral resolution limitations of instrument rather than to inherent structural properties of 
the system. In addition, the fluorescence intensity of main band of lanthanide complex is very 
strong although its quantum yield is usually lower than that of conventional fluorophores. The 
reason is that the transferred energy is largely emitted by the line-like main band. The narrow 
emission bands also offer the possibility for the multiplex assays without overlapping spectra. 
Third is the long fluorescence decay time (10 – 2000 µs). The f-f electronic transitions 
of lanthanide are forbidden, leading to long excited state decay time. Decay times of 
Chapter 1. Introduction 
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lanthanide complexes are quite sensitive to the detailed nature of the ligand environment, and 
especially to the number of water molecules occupying inner coordination sites. The 
forbidden f-f transitions is also reflected in low extinction coefficients, making direct 
photoexcitation of lanthanide ions rather difficult, and requiring organic ligands for energy 
absorption. The relatively long  decay times of lanthanide complexes have greatly facilitated 
the time-resolved fluorometry. 
1.1.2. Time-Resolved Fluorescence Assays 
The fluorescence decay time [5, 8, 11] is one of the most important characteristics of a 
fluorophore. There are mainly two kinds of method used for the measurement of the 
fluorescence decay times, namely time-domain or pulse fluorometry and frequency domain or 
phase-modulation fluorometry. In this dissertation, only time-domain methods will be 
discussed. 
Compared with the lanthanide complexes, the conventional fluorophores have relative 
short decay times between 5-100 ns. The decay times of most light source background, such 
as Tyndall, Raman scatter, Rayleigh scatter, and sample background, such as cuvette, plate, 
and sample matrix (protein, NADH, etc), are around 0.1-10 ns. So the gated fluorometry 
based on the lanthanide complexes can be used as shown in Fig. 1.2. 
The gated fluorescence experiment starts with the excitation pulse, but does not 
measure the fluorescence emission until the background has decayed to zero or minimum by a 
temporal lag. As lanthanide complexes have longer lifetimes, the background should be 
possible to be eliminated entirely. The sensitivity and selectivity of determination can be 
therefore improved. 
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Figure 1.2.  Principle of time-resolved (gated) fluorescence assay 
 
The µs scale decay time of lanthanide complexes have also greatly facilitated their decay 
time determination. The decay time based fluorometry has the following advantages: (1) 
decay time is the inherent characteristics of fluorophores, not affected by the concentration of 
fluorophores and photobleaching. (2) decay time is independence of the light source 
fluctuation. (3) decay time of lanthanide complex is only sensitive to its microenvironment, 
such as water in inner coordination field. With the development of fluorescence theories and 
instruments, there have been a lot of applications of lanthanide fluorescence as in different 
time–resolved determination [5-8] and imaging [12, 13]. There have been several techniques 
developed, such as lifetime based time-correlated single photon counting (TCSPC) and rapid 
lifetime determination (RLD) in time-domain fluorometry. Time-resolved fluorometry can 
also been applied in anisotropy (polarization) detection as time-resolved anisotropy [14]. 
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1.2. Time-Resolved Detection of Lanthanide Fluorescence for Bioassays 
Fluorescence lanthanide chelates have been successfully developed as labels and probes 
for the highly sensitive and selective bioassays in the past two decades. Time-resolved 
fluorescence detection [15, 16] has been widely applied in fluoroimmunoassay, DNA 
hybridization assay, enzyme assay, cell activity assay, and fluorescence imaging microscopy. 
According to the necessity of analyte immobilization, these bioassays can be broadly 
classified into heterogeneous and homogeneous fluorescence determination. Although the 
latter, especially utilizing the principle of fluorescence resonance energy transfer (FRET) [17, 
18] , has shown powerful potentials, it does not yet surpass the solid phase fluorescence 
bioassay in sensitivities, selectivities and virtual applications now. In the following, the three 
main approaches for time-resolved lanthanide fluorescence in heterogeneous phase, direct 
lanthanide chelate label-based luminescence assay (DLCLLA), dissociation enhanced 
lanthanide fluoroimmunoassay (DELFIA) and enzyme-amplified lanthanide luminescence 
(EALL), will be discussed in some details. 
 
1.2.1. Direct Lanthanide Chelate Label-based Luminescence Assay (DLCLLA) 
In contrast to other analytical methodologies (DELFIA and EALL), the experimental 
protocol of DLCLLA is simple. Its measurement principle (in Fig.1.3.) is that recognition 
molecules are labeled with fluorescent lanthanide chelate, being used to capture an analyte. 
The fluorescence intensity from label reports the quantity of analyte captured after excess 
labeled recognition molecules are washed off.  
Chapter 1. Introduction 
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Figure 1.3. Scheme of  DLCLLA  
Recognitions include immunoaffinity or hybridization.  
 
 
But an ideal fluorescence lanthanide chelate for DLCLLA is not easily achieved because 
the lanthanide chelate as label must undergoes the whole experiment processes including 
labeling reaction, recognition reaction and several rinses. Thus, there are some strict 
requirements for lanthanide chelate [15]: (a) high luminescence in water, (b) chemically and 
photochemically stable, (c) high metal-chelate binding constant and the presence of contain 
reactive groups appropriate for effective labeling reactions.  
Many synthetic organic chelators (see Fig. 1.4) have emerged. 4,7-Bis-
(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA) [19, 20] as ligands 
binding Eu3+ was the first commercial reagent for direct time-resolved fluorescence bioassay. 
It has been other applied in immunoassays [21], Western blots [22] and membrane based 
nucleic acid hybridization assay [23]. Subsequently, polyamino-polycarboxylate compounds 
and cage-type ligands have been synthesized, such as trisbipyridine cryptate (TBP), 4'-(3-
isothiocyanato-4-methoxyphenyl)-6,6''-bis[N,N-bis(carboxymethyl)aminomethyl)-2,2';6',2''-
terpyridine (TMT), and others. [Eu3+-TBP] can be used the detection of specific amplified 
Chapter 1. Introduction 
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Figure 1.4. Chelators for lunimescent lanthanide labels. 
target DNA [24, 25], but it is more often used in homogeneous detection for biomolecular 
interaction via FRET [16]. [Eu3+-TMT] was employed for the determination of protein and 
DNA samples [26] and its limit of detection is approx. 10-16 mol. Many lanthanide β-
diketonate chelates also display intensive fluorescence, but a few are suitable for the 
requirement of DLCLLA, for example, BHHCT  [27] and BTOT [28] (Fig. 1.4.). They have 
been used in albumin and IgE assays [29]. Other β-diketonate compounds, e g. 1,10-
bis(thiophene-2´-yl)-4,4,5,5,6,6,7,7–octafluorodecane-1,3,8,10-tetraone (BTOT) [30] and 
4,4´-bis(1’,1’,1’-trifluoro-2’,4’-butanedione-6’-yl)-chlorosulfo-o-terphenyl) (BTBCT) [31] 
have also been reported. 
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Figure 1.5. Scheme of  DELFIA 
Recognitions include immunoaffinity or hybridization. 
 
1.2.2. Dissociation Enhanced Lanthanide Fluoroimmunoassay (DELFIA) 
In lanthanide chelate based fluorescence detection systems, DELFIA [32, 33] is the most 
widely utilized approach. Its principle (Fig. 1.5) is that recognition molecule is labeled by the 
lanthanide chelate, which has a strong binding ability, but no or much weak fluorescence 
itself in the assay medium. After specific binding reaction for the analyte has been performed 
and the non-bound fraction of the label molecule has been efficiently washed away, 
lanthanide ion must be dissociated and released from the lanthanide chelate label, then enter 
an enhancement solution and micelle environment in which it coordinates new ligand and is 
measured via fluorescence. 
In DELFIA [32-36] diethylene-triaminetetraacetic acid or the derivative of 
ethylenediaminetetraacetic acid (EDTA) as chelating agent coordinates with europium ion to 
form lanthanide chelate label, such as, isothiocyanatophenyl–EDTA-Eu3+. Dissociative 
enhancement solution usually includes β-naphthoyltrifluoroacetone (NTA) as the energy 
transfer chelator, trioctylphosphine oxide (TOPO) as synergistic ligand, and Triton X-100 as 
detergent. In phthalate buffer at low pH 3.4, the stability of lanthanide chelate label is strongly 
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decreased in comparison to NTA present in the solution in large excess. Under these 
conditions the ligand exchange reaction is completed very fast. A new chelate is formed with 
NTA and the remaining empty coordination sites are occupied with TOPO, which prevents 
aqueous quenching. The hydrophobic chelate formed is dissolved in a micellar detergent 
solution (Triton X-100), in which the high fluorescence intensity can be determined. 
This method has been employed in many areas, such as PCR [37], nucleic acid 
hybridization [38, 39], immunoassays [40] for hormones [41], steroid [42] and inhibitor [43], 
proteins in cells [44-45] , and drug discovery [46]. 
In addition, multiplexing DELFIA has been also developed. Its protocol is (a) the same 
chelators are used to ligate several of lanthanide ions and to form differently colored 
fluorescent lanthanide chelates; (b) these lanthanide chelates are labeled on different 
recognition molecules (or groups) in same system; (c) “co-fluorescence enhancement” 
solution is employed for fluorescence measurement [47, 48]. Due to the narrow emission 
peaks of lanthanides at different wavelengths and their different fluorescence lifetime, the 
combination of spectral windows and temporal windows can be employed for the 
optimization of the measurement parameters. Thus, maximal sensitivity and minimal signal 
loss are obtained. All labels can be determined simultaneously, even if one is present in a 
significant excess, which is based on co-fluorescence enhancement. Multiplexing DELFIA 
assays, such as Eu3+ and Sm3+ [49, 50], Eu3+ and Y3+ [51], or Eu3+, Sm3+, Tb3+ and Dy 3+ [52, 
53], have been reported. 
1.2.3. Enzyme Amplified Lanthanide Luminescence (EALL) 
The concept and experiment of EALL [54]  were first reported by Evangelista and co-
workers in 1991. It is a bridge to connect the two sectors of enzyme assay and lanthanide 
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Figure 1.6. Scheme of EALL 
Recognitions include immunoaffinity or hybridization. 
 
fluorescence assay. The basic principles of EALL is shown in Fig. 1.6. The label of 
recognition molecule is enzyme, not lanthanide chelate. After the analyte is recognized, 
substrate for enzyme is added. Its reaction product can associate with lanthanide ion to form 
fluorescence chelate to be detected. 
As many enzymes can catalyze different substrates to form a lot of different products, 
the wide application area of EALL can be predicted. Up to now, Eu3+ and Tb3+ as main 
lanthanide element are employed in EALL. Some enzymes, such as alkaline-phosphatase 
(AP), glucose oxidase (GOx), peroxidase (POx), galactosidase, esterase and catalase, have 
been employed in EALL as summarized in Table 1.1. As these enzymes are of high stability 
and sensitivity, they have been usually used as label in many biological recognition molecules 
and have been commercialized. 
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On the other hand, since the property of substrate as media will influence the 
fluorescence of the final lanthanide chelate, There are some stipulations [54]: a) the substrate 
does not absorb the excitation light efficiently in the absorption spectrum of lanthanide 
chelate; b) the substrate does not efficiently transfer the excitation energy to the chelated 
lanthanide; c) the substrate does not efficiently chelate the lanthanide. Now some substrates 
have been used in different enzymes, for example, salicylaldehyde (SA), 5-fluorosalicyl 
phosphate (FSAP), phosphate ester of diflunisal (DIFP) and other salicyl phosphate-derived 
compounds for AP; 4-hydroxyphenylpropionic acid (pHPPA) for POx.  
Since enzyme amplification cycling reactions, EALL has a very low limit of detection 
(Table 5.1). It is conceivable that, in the scheme of EALL, substrate may be also a strong 
fluorescent lanthanide chelate to yield no or weak fluorescence product by enzyme 
catalytically. So the determinations of GOx [67] and of catalase [68] can be considered as this 
scheme.  
In addition, some improved schemes from enzyme and lanthanide chelates have been 
presented. For example, Ioannou and co-workers [55] reported the two-round enzymatic 
amplification, first combined with tyramide signal amplification [56], then with EALL, so 
that the selectivity and sensitivity have been increased. 
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TABLE 1.1. MAIN APPLICATIONS OF ENZYME-AMPLIFIED LANTHANIDE LUMINESCENCE (EALL) 
 Target Enzyme Substrate Detection Chelates LOD Ref. 
1 Alkaline-phosphatase (AP) AP 5-fluorosalicyl phosphate (FSAP) FSA-Tb3+-EDTA 0.2 amol 54 
2 IgG AP 5-fluorosalicyl phosphate (FSAP) FSA-Tb3+-EDTA 5 pg 54 
3 Xanthine oxidase(XOD) XOD salicylaldehyde SA-Tb3+-EDTA 1 µUnits 54 
4 β-Galactosidase (Gas) GAs salicyl- β-D-galactoside SA-Tb3+-EDTA 90 amol 54 
5 Glucose oxidase (GOx) GOx 1,10-phenanthroline-2,9-dicarboxylic acid dihydrazide (PDAdh) PDA-Tb
3+-EDTA 2 fmol 54 
6 DNA fragment AP salicylaldehyde SA-Tb3+-EDTA 4 pg 57 
7 α-Fetoprotein (AFP) AP 5-fluoresalicyl phosphate (FSAP) FSA-Tb3+-EDTA 0.15 pg/mL 58 
8 α-Fetoprotein (AFP) AP phosphate ester of diflunisal (DIFP)  DIF-Tb3+-EDTA 5 pg/mL 59 
9 Horseradish peroxidase (HRP) HRP 4-hydroxyphenylpropionic acid (pHPPA) pHPPA (dimer )-Tb3+-EDTA +  2 x 10-12 mol / L 60 
10 IgG POx 4-hydroxyphenylpropionic acid (pHPPA) pHPPA (dimer )-Tb3+-EDTA +  3 µg/L 61 
11 Porcine liver esterase esterase acetic acid eater of bis(2-pyridylmethyl)-(2-hydroxyrbenzyl)amine 
bis(2-pyridylmethyl)-(2-
hydroxyrbenzyl)amine-Tb3+ 3 x10
-9 M 62 
12 DNA fragment (PCR) AP FSAP FSA-Tb3+-EDTA 1x10
3-2x105 
molecules 63
 
13 pBR322 plasmid DNA (dot-blot DNA hybridization) AP alkyl and aryl-substituted salicyl phosphates xSA-Tb
3+-EDTA 125 pg 64 
14 Interleukin 6 AP DIFP  DIF-Tb3+-EDTA 0.15 ng/L 65 
15 Tumor necrosis factor- α (TNF- α) AP DIFP  DIF-Tb3+-EDTA 0.2 ng/L 66 
16 Glucose oxidase (GOx) GOx glucose Tc-Eu3+-HP 0.32 mUnits/mL 67 
17 Catalase catalase tetracycline-Eu(III)-hydrogen peroxide  Tc-Eu 3+-HP? Tc-Eu(III) 0.046 Units /mL 68 
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From these discussions, some characterizations of these approaches can be concluded: 
(a) lanthanide chelate as labels are used in DLCLLA and in DELFIA, but requirements are 
different. Label in DLCLLA must have intense fluorescence, while that in DELFIA must 
have no (or weak) fluorescence. However, the lanthanide chelate in EALL is a probe, in 
which the label is an enzyme. (b) DLCLLA in principle and protocol is simple, some cases 
have even higher sensitivity than DELFIA. But its labeling chelates need much stronger 
fluorescence intensity and stability, thereby its applications are restricted. (c) DELFIA is a 
highly sensitive scheme as its processes of molecule recognition and enhance fluorescence are 
separated. However, this feature also prevents its application in cytofluorometry, in-situ 
immunostaining, etc although it has enough widely application area. (d) The good perspective 
of EALL may be conceivable as enzymes correspond to numerous substrates and products, 
and it can be connected to other technologies to improve its applications, but now the 
available substrates and lanthanide chelates are rather limited and need to further explored. 
1.3. Aim of Research 
The goal of this dissertation is to develop ternary europium-derived (different 
stoichiometry) fluorescent probe for bioassays in aqueous solution. There are three main 
aspects: the first is based on the europium-tetracycline-hydrogen peroxide (EuTc-HP) probe, 
which can be converted into europium-tetracycline (EuTc) by peroxidase (POx), so that the 
activity of POx and POx labeled biomolecules will be possible determined; The second is 
based on the changes of fluorescence of EuTc probe when ligated to hydroxy acid (or 
oxyanions). Citrate and the main intermediates in the Krebs cycle can be determined and 
imaged without enzymes or multi-enzyme systems. The third relates to fluorescent 
discrimination of enantiomeric malates in aqueous solution. 
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Different fluorescence technologies, namely conventional steady-state and time-resolved 
(gated) fluorescence detection, conventional and time-resolved (gated and rapid lifetime 
detection) imaging, are being applied.  
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Chapter 2. Determination of the Activity of Peroxidase 
                   via the EuTc-HP Probe 
2.1. Introduction 
Peroxidases are widely studied [1-3] across a range of scientific disciplines, and applied 
[4-6] in bioanalytical protocols, in chemical and biomedical research, and in the food and 
pharmaceutical industries in general. They are known for being sensitive to ultra-low 
concentrations of substrates and tolerant to relatively harsh conditions, and therefore probably 
among the most preferred enzyme labels in enzyme-linked immunosorbent assay (ELISA) 
[7], nucleic acid assay [8], high-throughput screening (HTS) [9], and histochemical staining 
imaging [10]. 
Quite a variety of methods is known for the determination of the activity of peroxidase 
(POx). Practically all are based on the fact that POx reacts with hydrogen peroxide and a 
second substrate. Numerous such second substrates [11, 12] (often referred to as hydrogen 
donors) are suitable for chromogenic, fluorogenic or other signal-generating purposes. As a 
result, kinetic assays have been developed based on spectrophotometry / reflectometry [13, 
14], fluorometry [15, 16], chemiluminescence [17-19], electrochemiluminescence [20] and 
electroanalysis [21-23]. Among the fluorometric methods, those based on time-resolution [24] 
are the most sensitive tools in biological assays. Surprisingly, there is only one report [25] on 
the application of time-resolved lanthanide luminescence (using Tb3+ ion) now, although it is 
a particularly attractive scheme for the determination of the activity of POx. 
A new and easily accessible fluorescent probe, the europium-tetracycline-hydrogen 
peroxide (EuTc-HP) complex, is presented here for the time-resolved detection of the activity 
of peroxidase. It is based on the findings that (a) H2O2 forms a strongly fluorescent system 
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Fig.2.1. HRP structure. The main components are the 
heme (blue), the essential calcium ions (red), and the 
three key aminoacid residues: the proximal (below 
the heme) and distal (above the heme) histidines 
(yellow) and the distal pocket arginine (cyan). 
(From: Radu L. Silaghi-Dumitrescu, ref.[12]) 
 
with the europium-tetracycline complex (EuTc) [26, 27], (b) this system (EuTc-HP) is 
decomposed by POx and reversed to the weakly fluorescent EuTc, and (c) the average 
lifetime of EuTc-HP (~60 µs) is about two times that of EuTc (~30 µs), which offers the 
possibility for a time-resolved assay of POx. The results presented here demonstrate that 
EuTc-HP can be used for a new type of fluorometric assay for the activity of POx. 
2.2. Results and Discussion 
2.2.1. Principle of POx Assay 
2.2.1.1. Structure and Reaction  
Mechanism of POx 
Among of POx, horseradish 
peroxidase (HRP) [1, 2] is the most 
comprehensively studied. Its 
structure [1, 2, 28] is shown in Fig. 
2.1. HRP is specifically discussed in 
this dissertation. 
The processes [1, 29, 30] 
through which hydrogen peroxide 
oxidizes the second substrate 
catalytically by HPR, compose of multi-step reactions in Fig. 2.2. In the figure, compound-I 
and compound-II are enzyme intermediates, and AH2 is the second substrate (hydrogen 
donor). •AH is a radical product which has several possible fates, depending upon its 
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Figure 2.2.  Proposed mechanism of HRP 
chemistry and environment of the reaction, to become a dimer, to react with another substrate 
molecule, or to attack another species causing cooxidation. 
Besides the Fe3+ in the centre of heme, the functional role of the key residues in the 
active site of HRP are very important in the processes of catalysis [1, 2, 31, 32]. The three 
amino acids, histidine 170 (H170), histidine 42 (H42) and arginine 38 (R38), synergistic act 
for the decomposition of H2O2. 
The kinetic mechanism scheme in Fig. 2.2 is generally considered as the following: (1) 
From HRP to compound-I is a complicated process [33, 34]. H2O2 forms the iron-peroxide 
bond via H170, then H42, R38 and H170 together promote heterolytic cleavage of the O-O 
bond leading to formation of the ferryl group, Fe=O, and formation of water which is a 
leaving group. (2) Second substrate joins the process of transferring compound-I to 
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Figure 2.3. Schematic diagram of the principle underlying the POx activity assay. EuTc and 
hydrogen peroxide form a strongly fluorescent complex that is decomposed by POx on addition of 
the second substrate phenol. 
 
compound-II. Electron transfer occurs to the porphyrin ring and the π-cation radical 
disappears [35, 36]. Proton transfer occurs to H42. (3) In the process of compound-II reaction 
to native HRP [37, 38], both proton and electron transfer occur to the ferryl group with second 
substrate, simultaneously reducing Fe(IV) to Fe(III) and forming water. 
The step of reduction of compound-II to native HRP is often rate-limiting in the POx 
catalytic cycle [39]. Sometimes the compound-I formation can possibly become the rate-
controlling step by limiting concentration of H2O2 and a large excess of second substrate, but 
the production of compound-II is never the rate-limiting step. Obviously, the different 
concentration and kind of substrates can be reflected in the change of velocity of catalytic 
reaction, which usually governs the activity of enzyme. 
2.2.1.2. Detection Scheme for POx 
EuTc is a fluorescent probe for hydrogen peroxide (H2O2) [26]. It is based on the finding 
that the complex formed between Eu3+ and tetracycline undergoes a large increase in 
fluorescent intensity on exposure to H2O2. The fluorescent complex formed between EuTc 
and H2O2 (referred to as EuTc-HP) can be reversibly decomposed by peroxidases to EuTc. 
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Hence, the EuTc-HP reagent, which is easy to prepare, is highly promising for the kinetic 
assay of peroxidases, their substrates, activators, and inhibitors. The principle of the assay is 
shown in Fig. 2.3. 
Phenol was used as the second substrate in this assay of POx because it is easily 
available, stable, does not absorb at the excitation wavelength for EuTc-HP (~400 nm), and 
does not give fluorescent products. In a system composed of EuTc-HP, POx, and phenol, the 
activity of peroxidase is proportional to the reaction rate, i.e. ∆F/min, where ∆F is the 
difference between the initial fluorescence intensity (F0) and the final fluorescence intensity 
(F), ideally both corrected for a (conceivable) blank. Unless excited with light (of λ 350 – 440 
nm), no light is emitted, thus excluding the possibility of chemiluminescence. 
2.2.2. Spectral Characterizations 
The excitation and emission spectra of EuTc-HP and EuTc are given in Fig. 2.4. Like in 
other lanthanide complexes, the photonic energy absorbed by the ligand (Tc) in the EuTc 
complex is transferred to the central Eu3+ ion with its typical emission [40-42] in the form of 
main line (5D0 ? 7F2) peaking at 613 and 618 nm (two peaks) and several side bands (Fig. 
2.4). The appearance of two main peaks is a clear indication of the change of the crystal field 
[41] around Eu3+. From the findings presented so far the proposal is that H2O2, on addition to 
EuTc, replaces at least one water molecule ligated to Eu3+. However, no significant redox 
reactions are involved. Rather, water ligand (acting as a strong quencher) is replaced by H2O2 
ligands. On addition of H2O2 and subsequent formation of the EuTc-HP complex, the 
intensity of the emission increases by a factor of about 15. On the other hand, the spectra of 
EuTc-HP do not significantly change on addition of phenol alone. In order to obtain the 
optimum fluorescence intensity of H2O2 in EuTc, the molar ratio of Eu3+:Tc is kept at 3:1. 
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Figure 2.4. Fluorescence excitation (left) and emission spectra (right) of EuTc and the EuTc-HP 
complex in MOPS buffer of pH 6.9. 400 µL of EuTc stock solution, 160 µL of 5 mM H2O2 and  
136 µL of 49 mM phenol, with MOPS to total volume 2 mL. (A), EuTc plus excesss HP; 
 (B), EuTc-HP plus phenol; (C), EuTc. 
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Figure 2.5. Effect of the concentration of H2O2 on the fluorescence decay profile of 
 EuTc-HP. From (A) to (E), the concentrations of H2O2 decrease from 300 to 60, 30, 12 
and 0 µM, respectively. All samples contain 500 µL of EuTc stock solution in a total 
volume of 2 mL. 
 
 
Chapter 2. Determination of the Activity of Peroxidase via the EuTc-HP Probe 
26 
Fig. 2.5. shows the fluorescence decay profiles of EuTc on addition of increasing 
concentrations of H2O2 from curve (E) to curve (A). EuTc and EuTc-HP have rather different 
decay patterns and decay times. An analysis of the data in Fig. 2.5 has indicated [26] that the 
decay profile of EuTc-HP can be fitted to a three-component model. The respective decay 
times are 10 µs (relative amplitude 17%), 34 µs (18%) and 61 µs (65%). The average decay 
time is ~60 µs. EuTc also has three components as 7 µs (40%), 24 µs (54%) and 53 µs (6%), 
with its average decay time ~30 µs only. From these results it is obvious that time-resolved 
measurements are best performed with a lag time of ~ 60 µs in order to selectively detect the 
EuTc-HP complex and minimize interference from EuTc, proteins and plates. 
2.2.3. Kinetic Studies 
The activity of POx is directly related to the change in the fluorescence intensity of the 
EuTc-HP system as shown in Fig. 2.6. In the absence of POx (curve A) only small changes 
0 5 10 15 20
0
10
20
30
40
50
G
F
E
D
C
B
A
flu
or
es
ce
nc
e 
in
te
ns
ity
time / min
 
Figure 2.6. Time trace of the decomposition of the EuTc-HP complex by POx and phenol 
(A), phenol added to the EuTc-HP system, in which including 50 µL of stock solution of EuTc, 
20 µL of 4 mM H2O2  and 1 7µL of 49 mM phenol,with MOPS to 250 µL total volume, but no 
POx; (B) to (F), kinetic trace in presence of 7.6, 22, 76, 220 and 760 mUnits/mL of POx , 
respectively; (G), no H2O2 and POx at all (EuTc alone).  
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are observed; these are ascribed to effects of temperature. As the activities of POx increase 
from (B) to (F), the slope increases, and this can be used to determine its activity. Curve (G) 
is a time trace of the system to which no H2O2 and no POx have been added (i. e. that of plain 
EuTc). It is worth noting that in the assay described here, fluorescence does not drop to zero 
but only from the level of the fluorescence of EuTc-HP to that of EuTc. Once formed, EuTc is 
not affected by POx. Incubation at elevated temperature accelerates the reaction, so that 
fluorescence intensity changes more rapidly and strongly. Therefore, lower activities of POx 
can be detected. The dynamic range of the determination can also be adjusted by the 
incubation time. 
It needs to be emphasized that POx as a protein itself does not induce the decrease of 
fluorescence intensity, and that there is no change of the fluorescence of EuTc-HP if only 
POx is added, without phenol as indicated in Fig. 2.7. Additionally, if POx is denatured by 
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Figure 2.7. The influence of substrate-phenol to the catalytic cycle of POx. 50 µL of EuTc stock 
solution in each well (total volum 250 µL). Concentrations of H2O2 and phenol are 0.5 and 4 
mM, the activity of POx is 0.012 U/mL.  
 
Chapter 2. Determination of the Activity of Peroxidase via the EuTc-HP Probe 
28 
heating, none of the kinetic effects were observed that are associated with the presence of 
active POx. 
2.2.4. Effect of Substrates 
H2O2 is not only a substrate of peroxidase, but also an enhancer of the fluorescence of 
EuTc. Fluorescence reaches a maximum on increasing the concentration of H2O2 from zero to 
1.5 mM. The increase in fluorescence also depends on the concentration of EuTc. The optimal 
condition is obtained when a solution containing 20 µL of 5 mM H2O2 and 50 µL of the EuTc 
stock solution in a total of 250 µL is applied for POx activity assay. 
As a result of the reaction mechanism of POx discussed in section 2.2.1.1, H2O2 is 
catalytically decomposed by POx, and the two phenoxy radicals formed undergo dimerization 
(and possibly other reactions). From a mechanistic point of view it is important to keep in 
mind that such assays work best if the concentration of the substrate (phenol) is much higher 
than that of hydrogen peroxide, since only in this case the activity of POx can be determined 
via the consumption of H2O2. No significant change in fluorescence was observed provided 
the concentration of phenol was ≤ 3.5 mM for the EuTc-HP system (0.4 mM H2O2). 
2.2.5. Optimization of the POx Assay 
Any changes in pH will produce two effects on the system. The first is on tetracycline 
which has several dissociable groups that also may bind europium ion [44]. Both the 
absorption and emission spectra of tetracycline are highly sensitive to pH. The maximum 
enhancement in the fluorescence intensity on addition of H2O2 occurs at pH 6.9 (6.7 – 7.2 are 
acceptable). The second effect is that on the enzyme, even though POx is rather robust and 
maintains its activity over the pH 5 – 10 range, albeit with varying activity [45]. A pH of 6.9 
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was chosen for further experiments since it results in a fairly strong fluorescence of EuTc-HP 
at acceptable enzyme activity. 
The buffers MOPS, HEPES, Tris, and phosphate were tested in the assay. It shows that 
MOPS buffer is the best, while HEPES has a slight quenching effect. Phosphate interferes 
most strongly since 12 µM of phosphate cause a quenching by 21% of the fluorescence 
intensity of EuTc-HP. Tris buffer does not significantly affect. However, its best buffer 
capacity is between pH 7.5 and 9.0, which is outside our preferred pH range. Therefore, a 10 
mM MOPS buffer of pH 6.9 was used throughout the experiments. 
Even though the temperature optimum for POx is reported [45] to lie between 40 and   
50 °C, the experiment was performed at 30 °C since this already gave adequate kinetics. 
Conceivably, higher temperatures may be applied in certain cases or if shorter reaction times 
are desired. 
The interferences by common cations and anions were studied and no significant effects 
were found [26] except for phosphate and citrate. Known interferants [42, 45] for the EuTc-
HP system, such as ascorbic acid, uric acid, and bilirubin if present in concentrations of > 6, 
40, 7, and 16 µM, respectively. 
2.2.6. Steady-state Fluorescence Intensity Assay 
For the conventional fluorescent intensity assay, 50 µL of EuTc stock solution in each 
well (total volume 250 µL), the dynamic range is between 8.5 × 10-5 and 4.5 × 10-2 Units/mL, 
with the limit of detection 7.0 × 10-5 Units/mL after incubating for 10 min. Such a low LOD 
suggests that this probe be used for enzyme-linked immunosorbent assays using POx as a 
label. 
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Figure 2.8. Calibration curve of the activity of POx by time-resolved fluorescence determination. 
50 µL of EuTc stock solution in each well (total volum 250 µL) 
2.2.7. Time-resolved Fluorescence Assay 
The principle of time-resolved fluorescence has been demonstrated in Fig. 1.2. Due to 
the long decay times of europium complexes, they are often used in time-resolved fluorescent 
assays which can effectively eliminate background fluorescence, such as the intrinsic short-
lived fluorescence of proteins and microtiter plates. In the assay presented here, it also can 
largely reduce the fluorescence of EuTc. From the decay profile and the experimental 
optimization, a lag time of 60 µs and an integration time of 40 µs were found to be the most 
appropriate for the POx assay. No significant improvement is found when the integration time 
is increased from 40 to 100 µs. For the determination of high activities of POx, a short 
incubation time is adequate as can be seen from Fig. 2.8. For the gated assay, the dynamic 
range is from 4.0 × 10-5 to 5.9 × 10-3 Units/mL, with a limit of detection (S/N = 3) of 1.0× 10-5 
Units/mL. 
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Figure 2.9. Effect of cyanide on the activity of POx. Each well (250 µL total volum) includes 22 µl 
of EuTc, 20 µl of 5 mM HP and 17 µl of 49 mM phenol. (A), cyanide added to the system, but no 
POx; (B) – (D), in presence of 0.2 Units/mL of POx plus cyanide in final concentrations of 440, 
67, or 2.2 µM, respectively; (E), plus 0.2 Units/mL of POx added, but no cyanide. 
2.2.8. Inhibitors of POx 
Cyanide is a strong but reversible inhibitor of POx [1]. It binds to the sixth coordination 
site of the ferric ion heme complex of POx which also binds H2O2. Thus, it retards or prevents 
the catalytic cycle [46, 47]. In order to demonstrate inhibition, the kinetics due to inhibition of 
POx as monitored by the EuTc-HP system is shown in Fig. 2.9. Curve (A) shows a time trace 
where cyanide was added to the EuTc-HP/phenol system, but in absence of POx. 
Fluorescence remains unaffected, and this is also true for cyanide concentrations of less than 
0.44 mM. Curve (E) shows an uninhibited kinetics, while curves (B), (C), and (D) 
demonstrate that POx is inhibited if cyanide is present in concentrations of 2.2 µM or higher. 
This indicates that (a) the rate of the decomposition of H2O2 by POx decreases with 
increasing concentrations of cyanide; and (b) the probe may also be used to determination the 
concentration of inhibitors cyanide and to monitor the change of activity of POx. 
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Other known inhibitors of POx include sodium azide, whose effect on the EuTc-HP 
system (both in presence and absence of POx) is the same as that of cyanide. Hydroxylamine, 
in contrast, exerts a quenching effect on fluorescence of the EuTc-HP even in the absence of 
POx. Consequently, azide (but not hydroxylamine) can be also assayed via its inhibitory 
effect on POx.  
2.2.9. Comparison with Known Fluorescent Methods for POx 
The main fluorescence detections for the activity of POx are summarized in Table 2.1. 
Since H2O2 is not directly detectable by optical signals (which is contrast to electrochemical 
detection), substantial efforts have been made to identify chromogenic, fluorogenic and 
chemiluminogenic second substrates. They express the relationship between the second 
substrate and the activity of POx. Among the fluorogenic substrates in Table. 2.1, 
homovanillic acid [11], p-hydroxyphenylacetic acid [15], p-hydroxyphenyl-propionic acid 
[16], Amplex Red [48] are widely used. Recently, new substrates such as 4-(N-
methylhydrazino)-7-nitro-1,2,3-benzooxadiazole [49] and 10-methylacridan-9-carboxy-
hydrazide [50] have also been developed. None of them have been explored for the time-
resolved determination of POx. However, Meyer and Karst [25] have presented an enzyme 
amplified lanthanide luminescence (EALL) method. It utilizes the ternary complex formed 
between Tb3+, EDTA and the oxidation product of ρ-hydroxyphenylpropionic acid which has 
a decay time of about 100 µs, thus enabling the gated determination and working best in 
presence of an enhancer such as CsCl. 
On the other hand, the direct determination of H2O2, rather than the optimization of the 
second substrate for POx, has been not fully explored yet. Theoretically, direct H2O2 
detection, which is independent of possible effects of the sometimes complicated second 
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substrate on POx, offers more advantages than the above-mentioned methods if sensitivity is 
comparable. Certain metal ion complexes also have been used for the determination of H2O2 
[51, 52] for example titanium complexes. While these methods enable the assay of H2O2 by 
photometry, they do not enable fluorescent or gated assays since the probes are not 
fluorescent. Conceivably, they also may be used for POx assay, but this has not been 
demonstrated yet. 
Compared to the above methods, the POx assay presented here is first direct H2O2 – 
based time-resolved fluorometric assay with comparable sensitivity. It does not require the 
addition of other enhancers, works best at neutral pH and can be applied to both intensity-
based and time-resolved determination of the enzyme. 
2.3. Conclusion 
The EuTc-HP probe presented here represents the first lanthanide probe suitable for POx 
determination via H2O2 at neutral pH. It enables a convenient and sensitive assay for POx, is 
easily accessible, and has the typical virtues of a europium probe including large Stokes shifts 
(thereby reducing background luminescence) and µs decay times. It demonstrates, as well as 
in follow works, the suitability of EuTc-HP as a probe for POx-associated ELISAs, nucleic 
acid hybridization assays, and in other bioassays. 
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TABLE 2.1. COMPARISON OF KNOWN FLUORESCENT METHODS FOR DETERMINATION OF POX ACTIVITY 
 
Name Structure ex/em (nm) LOD (reported) 
range 
(reported) 
ref. 
1 
Homovanillic acid 
(HVA) 
 
315/425 1 mU 1-10 mU 
11,15, 
16 
2 
Tyramine 
 
326/410 500 µU 500 µU-10 mU 
11,15, 
16 
3 3-(p-hydroxyphenyl) 
propionic acid 
(HPPA) 
 320/404 7.8 µU 7.8 µU-1 mU 16 
4 p-hydroxyphenethyl alcohol 
(p-tyrosol)  
320/404 15.6 µU 15.6 µU-1 mU 16 
5 
N,N´-Dicyamomethyl-o-
phenylenediamine 
(DCM-OPA) 
 
255,334, 353/455  21-150 pM 53 
6 
10-methylacridan-9-
carboxylatehydrazide 
 
357/510 4.6 x 10-14 M 5 orders of magnitude 50 
7 
o-phenylenediamine 
 
428/560 0.56 µU/mL (2mL)  54
 
NH
NH
CN
CN
N
NHNH2O
CH3
NH2
NH2
CH2CH2NH2HO
CH2COOHHO
H3CO
CH2CH2COOHHO
CH2CH2OHHO
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8 10-acetyl-3,7-
dihydroxyphenoxazine 
(Amplex Red)  
563/587 10 µU/mL 0.0-2 mU/mL 48 
9 
4-(N-methylhydrazino)-7-nitro-
2,1,3-benzooxadiazole 
(MNBDH) 
 
470/547  determination glucose with POx 49 
10 
tetra-substituted amino aluminium
phthalocyanine 
(TAAlPc) 
 
610/678 5.9 x 10-13 mol·L-1 0.0-3.94 x 10-11 mol·L-1 55 
11 
oxidation of pHPPA-Tb(III)-
EDTA, CsCl 
 
320/545 2 x 10-12 M 2·10-12 – 1.0 x 10-8 M 25 
12 EuTc-HP  390-410/618 10 µU/mL 14µU/mL -·2 mU/mL   
O
N
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N
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2.4. Experimental Section 
2.4.1. Reagents 
Peroxidase (EC 1.11.1.7., type I, from horseradish, 148 U/mg solid) was purchased from 
Sigma (Deisenhofen, Germany; www.sigmaaldrich.com). The activity unit used in this article 
is based on the one defined by Sigma: one unit will form 1.0 mg purpurogallin from 
pyrogallol in 20 s at pH 6.0 at 20 °C. All inorganic salts were obtained in analytical purity 
from Merck (Darmstadt, Germany; www.vwr.com) unless otherwise stated. All solutions 
were prepared in 10 mM 3-(N-morpholino)- propanesulfonic acid (MOPS) buffer of pH 6.9 
(Roth, Karlsruhe, Germany, www.carl-roth.de) unless otherwise specified. High-purity 
hydrogen peroxide (H2O2) as a 30% solution was from Merck. Europium(III) trichloride 
hexahydrate was from Alfa Products (Danvers, USA; www.alfa.com), tetracycline 
hydrochloride from Serva (Heidelberg, Germany; www.serva.de). Tris- (hydroxymethyl) 
aminomethane (TRIS) and 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) 
were from Sigma-Aldrich.  
The stock EuTc solution was prepared by mixing of 10 mL of 6.3 mM Eu3+ solution 
with 10 mL of a 2.1 mM tetracycline solution, then diluting to 100 mL with MOPS buffer. 
This reagent is also available from Chromeon GmbH (Regensburg, Germany; 
www.chromeon.com) and may be diluted to the concentration required. A 5 mM solution of 
hydrogen peroxide was prepared fresh daily. The 0.49 M phenol solution was stored at 4 °C 
and diluted as required.  
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2.4.2. Apparatus 
Absorption spectra were acquired on a Cary WinUV photometer (Varian, Australia, 
www.varian.com). Fluorescence studies of the effect of H2O2 and phenol on spectra the EuTc 
and EuTc-HP were performed on an SLM AB2 luminescence spectrometer (Spectronic 
Unicam; Rochester, New York, USA; www.thermospectronic.com). Fluorescence intensity 
and kinetics were acquired on either a Fluoroskan Ascent micro titer plate reader (from 
Thermo Labsystems, Helsinki, Finland; www. labsystems.com) or on a Tecan GENios+ 
micro plate reader (Tecan, Groedig, Austria, www.tecan. com). The excitation/emission filters 
were set to 405/620 nm, or 405/612 nm respectively. The 96-well micro titer plates were 
obtained from Greiner Bio-One GmbH (Frickenhausen, Germany; www.greiner- lab.com). 
The luminescence lifetimes of different concentration of H2O2 in EuTc were detected with a 
pulsed 392-nm laser (LDH-C-400, PicoQuant GmbH, Berlin, Germany; www.picoquant.de), 
and an H5783-P04 PMT detector (Hamamatsu) with multiphoton-counting board in a 
multipass cuvette. Data were processed wither by FluoFit (PicoQuant GmbH)  
2.4.3. Recommended POx Assay Protocol 
Place, in each well of a thermostatted (30 °C) 96-well micro titer plate, 50 µL of EuTc 
stock solution, 20 µL of 5 mM H2O2 solution, 17 µL of 49 mM phenol solution, and with 
MOPS buffer to make up to a final volume of 250 µL. After 10 min, POx solutions of 
activities ranging from 4.0 × 10-5 to 4.5 × 10-2 Units/mL are added, and the decrease in the 
time-resolved fluorescence intensity is recorded on the Tecan GENios + reader over typically 
5 to 60 min, depending on activity of POx, with a lag time of 60 µs and the integration time of 
40 µs. Conventional steady-state fluorescence was detected with the same samples and micro 
plates as described  above. 
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Chapter 3. Peroxidase as a Label for ELISA and  
                  Oligonucleotide Hybridization Assay 
3.1. Introduction  
Immunoassays and DNA hybridization assays as two main members of broad category 
of bioassays have been widely utilized in biochemical research [1-5], clinical diagnosis [6-8] 
and pharmaceutical industries [9,10]. With the development of the electronic and analytical 
technologies, immunoassays and DNA hybridization assays have been combined to improve 
de novo chip technologies [11-13], including the protein chip [14, 15] arrays. 
There are different analytical schemes in immunoassays, such as radioimmunoassay 
(RIA) [16], spectrophotometric immunoassay, fluorescence immunoassay (FIA) [17], 
chemiluminescence immunoassay (CLIA) [18] and electrochemical immunoassay (ECIA) 
[19]. RIA is the most sensitive method in all biological and medical assays, but its isotopic 
hazard potential have recently limited its wide application. The photoluminescence 
approaches are main stream for bioassays because they are more sensitive than ECIA. These 
technologies are also used in DNA hybridization assays [20-22]. 
Fluorescence imaging is a powerful means for presenting the distribution of species, 
but is possible only (a) if the species of interest has a fluorescence by its own (such as NADH, 
many flavins and porphyrins) [23, 24], (b) if the species of interest can be rendered 
fluorescent by attaching a label (for instance, in immunofluorescence and DNA fluorescence 
studies) [25, 26] or (c) if appropriate fluorescent probes are available for the species of 
interest (e.g. probes for pH, oxygen, ions, as in this case hydrogen peroxide) [27-29]. 
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Figure 3.1. Scheme of the principle of POx- ELISA using EuTc-HP 
In this chapter, POx as a label has been further explored in IgG and oligonucleotide 
detection, based on the measurement of the activity of POx studied in chapter 2. The 
fluorescence of EuTc-HP decreases if POx catalyzes the consumption of H2O2. The time-
resolved fluorescent assay for biological specimen has more advantages than the conventional 
steady-state fluorescence assay because of its ability to eliminate the background fluorescence 
of proteins and biological matrix. On the other hand, this probe can be used as a reversible 
molecular sensor for the imaging of POx-ELISA. 
3.2. Results and Discussion 
3.2.1. Principle of Fluorescence Detection of POx-ELISA 
IgG, as a model, is employed for POx-ELISA with EuTc-HP. Scheme of principle of 
POx as a label for sandwich ELISA has been shown in Fig. 3.1. Anti-IgG is first coated onto 
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Figure 3.2. Scheme of direct ELISA 
the polystyrene surface of microtiter plate, different concentrations of analyte IgG react with 
it after BSA has blocked the extraneous binding sites. EuTc-HP is added when the secondary 
POx labeled anti-IgG has recognized IgG, then after incubating, IgG can be determined via 
the fluorescence decrease of EuTc-HP because H2O2 is catalytically decomposed by POx. 
POx as a label for direct ELISA is shown in Fig. 3. 2. Instead of anti-IgG, analyte IgG is 
directly coated on the microtiter plate. Other processes are the same as Fig. 3.1. 
Detail protocols of sandwich POx-
ELISA and direct POx-ELISA are in 
experimental Section 3.4.3. 
 
3.2.2. Kinetic Studies of Sandwich POx-ELISA 
Fig. 3.3. presents the fluorescence change of the decomposition of  EuTc-HP probe by 
IgG versus POx labeled anti-IgG. Curve(A) is a time trace for blank, which coated anti-IgG 
same as other wells without target molecular IgG. (B) to (D) are curves of kinetic process of 
the concentrations of IgG versus the activity of POx-labeled anti-IgG. With the increasing 
amount of POx-anti-IgG, from (B) to (D), the slope of curve is increasing, which can be used 
to indicate the activity of POx. Therefore, the concentration of IgG can be determined by this 
method. The kinetic curve of the direct POx-ELISA is similar as this case. 
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Figure 3.3. Time trace of the decomposition of the EuTc-HP complex by IgG versus POx- anti-
IgG as monitored via fluorescence. (A) blank; (B) - (D) time trace after addition
3.2.3. POx – ELISA for IgG via the EuTc-HP Probe 
3.2.3.1. Steady-state fluorescence POx –ELISA 
The activity of peroxidase labeled on anti-IgG can be measured with the EuTc-HP 
fluorescence probe. The calibration curves (after incubating for 20 min, expressed as ∆F= (F0 
- F) of fluorescence) are shown in Fig. 3.4. It indicates that (a) for the sandwich POx-ELISA, 
its limit of detection is 0.1 ng/mL, and the linear range is between 0.3 - 6 ng/ml, r = 0.98; (b) 
for the direct POx-ELISA, its limit of detection is 2 ng/mL, and the linear range is between 10 
- 2000 ng/ml, r = 0.99; (c) the sandwich POx-ELISA with EuTc-HP fluorescent probe is more 
sensitive than the direct one. 
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Figure 3.4. Calibration plot of steady-state fluorescence detection for IgG by POx-Anti-IgG 
versus the decrease in fluorescence intensity (F-F0) over 20 min.F0 and F are fluorescence 
intensities of blank and sample. 
 
3.2.3.2. Time-resolved fluorescence detection of POx-ELISA 
One of the advantages of time-resolved fluorescence of ELISA is suppression of the 
background fluorescence, especially that from biological samples. This experiment is 
performed and recorded with a time lag of 60 µs after the pulsed excitation light source is 
switched off. The best integration time was found to be 40 µs. Fig. 3.5. shows the resulting 
normalized calibration plot for this linear range, which was obtained by plotting the 
normalized fluorescence [(F0 – F) / F0] versus the concentration of IgG. The limit of detection 
of this time-resolved fluorometric sandwich POx-ELISA is calculated to be 0.1 ng/ml of IgG. 
The linear range is from 0.1 to 8.0 ng/ml. For direct POx-ELISA, the linear range is from1.0 
to 88.0 ng/mL, with 1.0 ng/mL of limit of detection. Obviously, the sandwich POx-ELISA is 
more sensitive than direct POx ELISA whether in conventional steady-state or in time-
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Figure 3.5. Calibration plot of time-resolved  detection for IgG by POx-Anti-IgG versus the 
decrease in fluorescence intensity (F-F0 ) over 20 min, with 60 µs lag time and 40 µs integration 
time. F are fluorescence intensities of blank and sample. 
 
Figure 3.6 Scheme of imaging 
 
resolved fluorescence detection. Both methods have enough good sensitivity and is suitable 
for the requirements of regular clinical assay. 
3.2.3.3. Time-resolved fluorescence imaging ELISA (TRFI-ELISA) 
The pathway of light  of imaging [29] is 
indicated in Fig. 3.6. As in conventional 
fluorescence reader, all spots of the 
microtiter plate can be excited 
simultaneously with a pulsed 96-LED array 
(λmax = 405 nm). The light from the pulsable 
LED array passes an excitation filter and hits 
the wells of the microtiter plate. The 
emission from the fluorescent sample is 
filtered by an excitation filter and is detected 
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Figure 3.7. Scheme of time-resolved imaging 
 
by the CCD camera.  
The camera is gated during the total exposure by an external trigger signal. The lag time 
and integration time are 60 and 40 µs after the LEDs were switched off (Fig. 3.7). The 
detailed protocol is described as in section 3.4.7. 
    1           2          3          4        5          6         7          8        9         10        11 
cIgG [ng ml-1]        0         0.1     0.5        1         5         10      40        80      100           
F   169      577     402      396      386     423     383     355     311      251    208 
SD  20       22        4         28        52       58       29        8        37       13        6   
Figure 3.8. TRFI-ELISA for IgG. 
 F is the intensity value calculated from an area in the centers of the spots and averaged over three 
spots of equal concentrations. SD is the standard deviation in the spot regions. 
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Time-resolve fluorescence imaging-ELISA (TRFI-ELISA) for IgG was performed on a 
microtiter plate (protocol of sandwich POx-ELISA) after 45 min incubation of EuTc-HP 
probe at room temperature. The result is shown in Fig. 3.8 (false-color, value as arbitrary 
intensity). The dynamic range of this TRFI-ELISA is from 5 to 100 ng/mL for IgG. At high 
concentration of IgG, the complete decomposition of the EuTc-HP complex is readily 
observable. The time-gated fluorescence intensities from imaging decreased nearly to the 
values of the EuTc reference samples in spot column 1. The fluorescence intensities from 
imaging were calculated and averaged from the regions in the centers of the spots. The 
standard deviations between three different spots with the same IgG concentration are in the 
same magnitude (between 5-10 %). 
The advantage of imaging ELISA is the fast data acquisition and the clear and concise 
data visualization, which makes this method suitable for high-throughput screening 
applications.  
3.2.4. Principle of Competitive POx-Oligonucleotide Hybridization Assay 
Competitive oligonucleotide hybridization is a very popular method in nucleic acid 
assays [30-31], which can improve the selectivity of detection. The scheme of competitive 
oligonucleotide hybridization is shown in Fig. 3.9. Anti-biotin is coated on the surface of 
microtiter plate, then affinitively reacts with oligonucleotide conjugated biotin after BSA has 
blocked the extraneous binding sites. Complementary oligonucleotides with or without POx 
are added to undergo competitive reaction, after adding EuTc-HP, incubating, the 
fluorescence changes can be recorded for calculating the concentration of oligonucleotide. 
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Figure 3. 9.  Scheme of the principle of competitive POx-oligonucleic acid 
 hybridization assay  using EuTc-HP 
3.2.5. Fluorescence Detection of POx-Oligonucleotide Hybridization 
In this experiment, the 20 base sequence (TA) from a fragment of SLT1 (Shiga-like 
toxins), as a model, is employed. The sequence of TA is 5´-AAG TAG TCA ACG AAT GGC 
GA-3´. Horseradish peroxidase labeled TA is denoted as POx-TA. The complementary 
oligonucleotide for TA is cTA, which is biotinylated to form BcTA. (see section 3.4.1.) 
TA and POx-TA compete to hybridize with immobilized BcTA. The fluorescence 
change of the decomposition of EuTc-HP probe by POx-TA is used to evaluate the 
concentration of TA. In the low concentration of TA from 0-2.8 nM, a linear relationship with 
fluorescence change is obtained, but in high concentration of TA, the results are not so good. 
The possible reason is that TA is only a 20 base pairs nucleotide, while POx-TA has a 
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Figure 3.10. Calibration curve of competitive hybridization of TA and PTA, 
 total concentration[TA]+[PTA]= 5 nM  
macromolecular protein label, thus competition of POx-TA at low concentration is weaker 
than that of TA. 
3.3. Conclusion 
EuTc-HP as a typical europium probe for bioassay, it need not label or conjugate on 
protein or DNA. So it is easily prepare and procedure besides it has the merits of lanthanide 
complex fluorescence. The rate of consumption of the EuTc-HP system as monitored via the 
decrease in fluorescence intensity is a direct parameter for (a) the activity of the POx, (b) IgG 
versus POx-labeled-anti-IgG, and (c) oligonucleotide versus POx-oligonucleotide  
(competitive reaction). From above experiments, it is a evidence that the EuTc-HP can be 
utilized in bioassays via fluorescence intensity and imaging technologies.  
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3.4. Experimental Section 
3.4.1. Reagents 
Rabbit anti-bovine IgG, bovine IgG, rabbit anti-bovine IgG / peroxidase conjugate, BSA 
were purchased from Sigma (Deisenhofen, Germany; www.sigmaaldrich.com) and used 
without further purification. Sequence of TA from a fragment of SLT1 (Shiga-like toxins) in 
EHEC (Enterohemorrhagic E. coli) is 5´-AAG TAG TCA ACG AAT GGC GA-3´. There are 
no self-complementarity and no hairpin-loop in TA. POx labeled TA (POx-TA) is HRP-5´-
AAG TAG TCA ACG AAT GGC GA-3´ and biotinylated complementary oligonucleotide for 
TA (BcTA) is Bio-5´-TCG CCA TTC GTT GAC TAC TT-3´. They were purchased from 
Thermo Hybaid (www.thermohybaid.com) 
All inorganic salts were obtained in analytical purity from Merck unless otherwise 
stated. Europium(III) trichloride hexahydrate was from Alfa Products, tetracycline 
hydrochloride from Serva.  
The stock EuTc solution was prepared by mixing of 10 mL of a 6.3 mM Eu3+ solution 
with 10 mL of a 2.1 mM tetracycline solution, then diluting to 100 mL with MOPS buffer. 
High-purity hydrogen peroxide (H2O2) as a 30% solution was from Merck. A 5 mM solution 
of hydrogen peroxide was prepared fresh daily. The 0.49 M phenol solution was stored at  
4 °C and diluted as required.  
PBS buffer (0.26 g KH2PO4, 2.17 g  Na2HPO4·7H2O and 8.71 g of NaCl in 800 mL 
distilled water, adjusted to pH 7.4 with 1.0 M HCl or NaOH) to the corresponding working 
concentrations, then dilute to 1000 mL. 20 x SSC buffer: dissolve 175.3 g of NaCl and 88.2 g 
of sodium citrate in 800 mL, adjusted to pH 7.0 with  HCl or NaOH, then dilute to 1000 mL. 
Chapter 3. Peroxidase as a Label for ELISA and Oligonucleotide Hybridization Assay 
53 
According to requirements, diluted to 1 x SSC (saline sodium citrate), 1 x SSC + 1% SDS 
(sodium dodecyl sulfate), 1 x SSC+1% triton-X-100.  
3.4.2. Apparatus 
Fluorescence intensity and kinetics were acquired on either a Fluoroskan Ascent micro 
titer plate reader (from Thermo Labsystems, Helsinki, Finland; www. labsystems.com) or on 
a Tecan GENios+ micro plate reader The excitation/emission filters were set to 405/620 nm, 
or 405/612 nm respectively.  
3.4.3. Protocol of POx-ELISA 
The scheme of sandwich POx-ELISA is shown in Fig. 3.1.  
1).Coating antibody on the microtiter plate: Use 200 µl of Rabbit anti-Bovine-IgG at a 
concentration of 5 µg/mL in 10mM of PBS at pH 7.4, add to each well of a polystyrene 
microtiter plate, incubate at 37 °C for 1 hour. Alternatively, incubate at 4 °C overnight. 
2).Blocking extraneous binding sites: Block remaining binding sites in each well by 
incubating with 200 µl of 1% BSA in 10mM of PBS at pH 7.4, incubate at 37 °C for 30 min. 
3).Reacting with analyte: Add 200 µl of different concentrations Bovine IgG to each 
well, incubate at 37 °C for 1 hour. 
4).Reacting with POx labeled secondary antibody: Add 200µl of rabbit anti-bovine IgG 
peroxidase conjugate at 1:1500 in each well, incubated at 37°C for 1 hour.  
Between above two times coating, rinse 3 times by 10 mM PBS at pH 7.4.  
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Last rinse before fluorescence assay, MOPS buffer was used to avoid residual PBS 
contaminating the EuTc-HP, and ready for detection (section 3.4.5) 
For direct POx-ELISA, analyte IgG was coated onto the microtiter plate, other processes 
are same as sandwich POx-ELISA. 
3.4.4. POx-Oligonucleotide Hybridization Assay 
The scheme of POx-oligonucleotide hybridization assay is shown in Fig.3.9.  
1).Coating antibody on the microtiter plate: Use 200 µl of Rabbit anti-biotin-IgG at a 
concentration of 5 µg/mL in 10 mM pH 7.4 of PBS, add to each well of a polystyrene 
microtiter plate, incubate at 37 °C for 1 hour. Alternatively, incubate at 4°C overnight. 
2).Blocking extraneous binding sites: Block remaining binding sites in each well by 
incubating with 200 µl of 1% BSA in 10mM pH 7.4 of PBS, incubate at 37 °C for 30 min. 
3).Affinity reaction with biotin-oligonucleotide: Add 200 µl of 5 nM BcTA in 10 mM 
pH 7.4 of PBS in each well, incubate at 37 °C for 1 hour. 
Between above two times coating, need rinse 3 times by 10 mM pH 7.4 PBS.  
4).Competitive hybridization:  Mix different concentration of oligonucleotides of TA 
and POx-TA in hybridization solution (5 x SSC and 1% SDS ) in each well. Incubate for 10 
min at 50 °C or 30 min at 45 °C with agitation. 
5). Post-hybridization washes 
(a) add 200 µl of preheated wash solution 1 (1 x SSC, 1 % SDS) in each well, at 40 °C 
for 10 min, with shaking 
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(b) add  200 µl of wash solution 2 (1 x SSC, 1 % Triton X-100) in each well, at 40 °C for 
10 min, with shaking 
(c) add 200 µl of preheated wash solution 3 (1 x SSC) in each well, at 40 °C for 10 min, 
with shaking. 
Last rinse before fluorescence assay, MOPS buffer was used to avoid residual SSC 
contaminating the EuTc-HP, and ready for detection (section 3.4.5) 
3.4.5. Fluorescent Intensity Detection 
Time-resolved fluorescence detection: 250 µL of EuTc-HP- phenol analytical solution, 
which including 50 µL of EuTc standard solution, 20 µL of 5 mM H2O2, 17 µL of 49 mM 
phenol and other 10 mM of MOPS in 6.9 pH, was added to each well of samples 
(immunoassay and oligonucleotide hybridization assay). The kinetic curve and the end – point 
of fluorescence intensity of EuTc-HP system after incubating 20-60 min was record, 
depending on POx-anti-IgG or POx-TA. Time-gated fluorescence was with a lag time of 60 
µs and the integration time of 40 µs. Steady-state fluorescence was detected with the same 
samples and micro plates as described  above without lag time. 
3.4.6. Imaging Set-up 
The set-up of the self-developed imaging system was used for time-resolved imaging of 
the emission intensity as described by Liebsch et al [29] and Schaeferling et al [32] in Fig. 
3.11. Imaging detection system consists of a fast gatable CCD-camera, a pulsable LED array 
with 96 UV light emitting diodes (λmax = 405 nm), a 96 fiber light-guiding adapter, a pulse 
generator, optical excitation and emission filters, and a personal computer for controlling and 
visualization of the experiments. The pulsed data were acquired process with the 
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Figure 3.11. Scheme of the imaging setup 
corresponding software modules. The images were processed, visualized and evaluated with 
the IDL software module (Research Systems, Inc., Boulder, CO). 
Optical system in imaging set-up: 
1) CCD camera: The camera had a black/white CCD chip with 640x480 pixels (307200 
pixels, VGA resolution) and a 12-bit resolution, equivalent to 4096 gray-scale values. The 
CCD chip can be gated directly with a minimal trigger time of 100 ns, additional image 
intensification is not required. and camera is triggered by a pulse generator. 
2) LED array: The LEDs (λmax = 405 nm) were arrayed fitting exactly to wells of a 96-
well microtiter plate for single illumination of each well by one LED, and LED array was 
pined to the electronic board, which enables a quick exchange by  LED emitting of different 
wavelengths. 
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3) Light-guiding adapter: There are 96 optical fibers in light-guiding adapter for reduces 
the imaged area to fit the standard optics of the imaging set-up. This enables the simultaneous 
evaluation of 96-well at the same time. 
3.4.7. Imaging  
The camera is gated during the total exposure by an external trigger signal. The 
excitation pulse had a width of 90 µs, the lag time was fixed to 60 µs, with a time window 
from 150-190 µs after the LEDs were switched off. The resulting image is an added 
superimposition of this single pictures. The corresponding background images were recorded 
in a second acquisition cycle within the same time gates without prior excitation and finally 
subtracted from the emission signals. The whole imaging process for the read-out of a 
microtiter plate is accomplished, using three consecutive acquisition cycles for data 
evaluation and quantification. 
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I: Fischer projection ;   II: Wedge projection 
 
Chapter 4. Fluorescence Determination and  
                  Imaging of Citrate 
4.1. Introduction 
Citrate (Fig. 4.1) is an ubiquitous 
natural compound that occurs in all living 
cells since it is an important intermediate 
in the Krebs cycle (also referred to as the 
citrate cycle or the tricarboxylic acid 
cycle) [1, 2], which is the central 
metabolic hub of the cell. Besides its 
function in cell metabolism, citrate is also widely studied for other fields. In environmental 
sciences, as a popular chelating agent that assists in the elimination of heavy metal ions 
through being uptaken and biotransformed by bacteria [3-6]. In medicine, citrate is used as an 
anticoagulant [7-9] to prevent blood clotting, and for the evaluation of urinary citrate 
excretion which in turn is related to kidney stones, renal tubular acidosis and certain bone 
diseases [10-12]. It is also widely utilized as an additive in the food and pharmaceutical 
industry [13, 14]. 
Citrate does not have significant physical and chemical properties suitable for direct 
determination in complex systems, and therefore is difficult to detect and visualize. There are 
many indirect methods have been exploited, such as by separation technique (such as. high 
performance liquid chromatography [15-18] and capillary electrophoresis [19-21]), or by 
enzymes for transformation and synthetic receptors for recognition (Table 4.4). 
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In most of enzyme-based assays [22], two enzymes, citrate lyase (CL) and malic 
dehydrogenase (MDH), are usually employed and the decomposition of NADH is detected by 
absorbance at 355 nm or fluorescence at 445 nm. However, this method would have serious 
limitations including (a) the need for UV excitation at 355 nm (where almost all materials 
display fluorescence and background therefore would be strong); (b) the short decay time of 
NADH (3-5 ns) which hinders the application of time-resolved fluorescence assay and 
imaging with its unique advantages in terms of background suppression; and (c) the method 
needs reactions by enzyme catalytically and has rather complicated protocols. So far, 
however, no direct, intensity based or time-resolved fluorescence assays and imaging for 
citrate has been reported. 
The fluorescence enhancement of citrate on EuTc has been unexpected observed during 
the studies of interference on EuTc-HP system. This offers a direct method for the fluorescent 
time-resolved detection of citrate without the involvement of enzymes. So here a europium 
derived fluorescent probe for the detection and visualization of citrate will be presented. The 
method is based on the finding that the weak fluorescent europium-tetracycline (EuTc), 
associates with citrate to form a strongly fluorescent europium-tetracycline-citrate (EuTc-Cit) 
complex in neutral pH. The features of lanthanide fluorescence of EuTc-Cit are suitable for 
the time-resolved determination and rapid life detection imaging. 
4.2. Results and Discussion 
4.2.1. Characterization of EuTc-Cit 
4.2.1.1. Spectra of EuTc-Cit 
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Figure 4.2. Spectra of citrate (150 µM) in EuTc(50 µM of  Eu3+ and Tc)  
 
The fluorescence properties of EuTc have been presented before [23, 24] including its 
application for detection and visualization of hydrogen peroxide [25, 26]. The absorption and 
fluorescence spectra of the EuTc-Cit system are shown in Fig. 4.2 and their characteristics in 
Table. 4.1.  
TABLE 4.1. THE CHARACTERISTIC PARAMETERS OF IN EUTC-CIT 
(citrate: 150 µM, Eu3+: 50 µM, Tc: 50 µM) 
 EuTc EuTc-Cit 
absorption peak (nm) 390 389 and 401 
molar absorptivity ε 
(L mol-1 cm-1) 
1.76 x 104 2.05 x 104 
emission (nm) 616 615 
average lifetime (µs) 44 83 
QY (%) 0.4 3.2 
 
The maximal absorbance of EuTc-Cit are from 381 to 408 nm, similar to that of EuTc. In 
contrast, the intensity of the emission of EuTc-Cit at 615 nm is much stronger than that of 
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EuTc. This line-like emission is due to the 5D0→7F2 electronic transition which is typical for 
Eu3+ fluorescence, with other side bands at 580, 590, 651, and 697 nm, respectively. The 
quantum yield (QY) of EuTc-Cit increases to 3.2 % from 0.4 % in case of EuTc, (as referring 
to tris (2,2’-bipyridyl) dichlororuthenium(II) hexahydrate) [27]. In EuTc-Cit complex system, 
citrate, in being a polydentate ligand, can chelate with Eu3+ to form poly-ring via the oxygen 
atoms of carboxyl and hydroxyl groups [28-30]. It is assumed that citrate displaces water 
molecules, which ligate to the inner coordination field of Eu3+ and quenching its fluorescence. 
Obviously, the energy transfer in EuTc-Cit is much more effective than that in EuTc. 
4.2.1.2. Decay time of EuTc-Cit 
The decay profile of EuTc-Cit can be fitted to a three-component model, with decay time 
components of 15 µs (relative amplitude 12 %), 58 µs (33 %) and 95 µs (55 %), respectively, 
with an average lifetime (important with respect to imaging) being 83 µs. For EuTc, the three-
component model is composed of 8 µs (41 %), 24 µs (55 %) and 123 µs (4 %), respectively, 
with a average lifetime of 44 µs. The time-resolved fluorescence detection of citrate will 
benefit from these features of the decay times. 
4.2.1.3. Composition of EuTc-Cit 
The continuous-variations (or Job´s) method (Fig. 4.3) has been employed for the 
detection of molar ratio of Eu : Tc : Cit. In Fig. 4.3(a), while the concentration of citrate is 
excess, the mole fraction of Eu3+ : Tc are continuously changed while keeping the total 
concentration at 25 µM. The peak of curve is at 0.5 of mole fraction of [Eu3+] / ([Eu3+] + [Tc], 
namely molar ratio of Eu:Tc is 1:1. Changing total concentration to 37.5 and 50 µM, the same 
result is obtained. Similar case is shown in Fig. 4.3(b) with mole fraction of [Tc] / ([Tc] + 
[Cit]) being 0.33. Other total concentration of Tc and citrate, 37.5 and 50 µM, are also 
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Figure 4.3. Continuous-variations method (Job´s plot) 
 
employed in this experiment. The result indicates that the molar ratio of Tc: Citrate is 1:2. In 
combination of Fig. 4.3(a) and (b), the mole ratio of Eu:Tc:Cit is 1:1:2, namely EuTc(Cit)2. 
It is noted that the molar ratio of Eu3+ : Tc in EuTc-HP system (chapter 2 and 3) is 3:1. 
The 1:1 of molar ration of Eu3+ : Tc will be used in EuTc - hydroxy acid system (chapter 4, 5, 
and 6). 
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Figure 4.4. CD  spectra of EuTc-Cit, EuTc and Tc 
Concentrations of Eu3+, Tc and citrate are 50, 50 and 150 µM, respectively. 
Since the molar ratio of (EuTc):citrate is 1:2, there are two dissociation constants Kd1 
and Kd2 for EuTc-Cit. The disassociation constants are roughly estimated by the Benesi-
Hildebrand type equation for a two binding site saturation [31-33]: the pKd1 and pKd2 are in 
the range of 4.0 – 5.0. 
4.2.1.4. Spectra Circular Dichroism 
The circular dichroism (CD) spectra are mainly used for the characterization of chiral 
compounds and secondary structure of proteins or other biologically important molecules. 
Tetracycline [34] as chiral molecule, [ ]25Dα  - 257.9° (0.1 N HCl), [ ]25Dα  - 239° (methanol), has 
five chiral carbons. The spectral change in CD from tetracycline binding Eu3+ is shown as in 
Fig. 4.4. The CD spectrum of tetracycline consisted of two intense exciton couplets 
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Figure 4.5. Solid form of EuTc-Cit in UV light (left) with 470 nm cut-off objective lens;  same 
EuTc-Cit in white light (right) with common objective lens. Two photos were obtained on Leica 
DMR fluorescence microscope. 
 
(maximum at 296 nm, minimum at 271 nm and at 324 nm) with two crossover at 282 nm and 
at 311 nm. The CD spectra of Tc in ligand of Eu3+ or in free state have significant differences. 
The spectral changes from EuTc are expressed that three bands at 242, 267, and 290 nm 
instead of one crossover at 282 nm from Tc; a new crossover at 385 nm is occurred 
(maximum at 408 nm and minimum at 373 nm) which is assumed from the absorption of 
EuTc around 400 nm (Fig. 4.2). But spectra of EuTc in absence and in present citrate is 
similar, with only have a little changes. In this case, EuTc is an asymmetric probe, citrate 
ligating EuTc form ternary complex which is also asymmetric. It indicates that citrate does 
not significant influence the structure of EuTc at least at ground state. 
4.2.1.5. Solid form of EuTc-Cit 
The EuTc-Cit shows strong fluorescence not only in solution, but also in solid. Fig. 4.5 
(left) is a microscopic photo for the solid EuTc-Cit under UV light. Significant red emission 
from Eu3+ is evident. Under white light, the common solid form of EuTc-Cit can be observed  
in Fig. 4.5 (right). 
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Figure 4.6. The influence of pH for EuTc-Cit. Concentration of Eu3+, Tc and citrate are 50, 50 and
150 µM, respectively. 
4.2.2. Optimal Experimental Conditions  
In EuTc-Cit, tetracycline and citrate as ligands have been deprotonated and are sensitive 
to pH. The acid dissociation constants of tetracycline [35-38] are pKa1 ~ 3-4, pKa2 ~ 7.3-8.1, 
and pKa3 ~ 8.8-9.8, that of citric acid [39] are pKa1 = 3.1, pKa2 = 4.7, and pKa3 = 6.4. But 
once the EuTc -Cit system is formed, it is stable in wide pH range from 7.4 to 9.2 in Fig. 4.6. 
In this pH range, Tc and citrate, can lose two and three protons, respectively, to become 
anions with multi-negative charges, and this facilitates binding to europium ion. 
Three different buffers (HEPES, MOPS and TRIS) were exploited (Fig. 4.6). All of 
them are suitable for the system. Since the optimal buffer range of MOPS is not coincidental 
with EuTc-Cit, and TRIS buffer is largely temperature dependent, a 10 mM of HEPES buffer 
solution of pH 8.0 is used in these experiment. 
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Figure 4.7. Time trace of citrate in EuTc-Cit. Concentration of Eu3+ and Tc are all 50 µM,  
D: blank (EuTc), A, B and C are 50, 15, and 10 µM of citrate. 
The time trace (Fig. 4.7) of EuTc binding citrate shows that the increasing of fluorescent 
intensity depends on time and the concentration of citrate. The higher concentration of citrate, 
the longer the time to form stable fluorescence.  
The fluorescence of EuTc-Cit is inversely proportional to the temperature, as most of the 
fluorophores. The temperature curve can be describe as y = 14.4 - 0.3 x, (x and y are 
temperature (°C) and fluorescence intensity). 
4.2.3. Interferences 
The interferences for EuTc-Cit systems, about 40 common cations in Table 4.2, anions, 
gases and small biomolecules, were studied. Oxygen has a small effect as its fluorescence in 
saturated air is 90% of the maximum intensity of that in nitrogen. Alkali, halide, sulfate, 
nitrate, ammonium, small organic molecules in serum, and human serum albumin (HAS) do 
not interfere. For heavy metals ions, at pH 8.0, since some of them are precipitated by OH-, 
only Ni2+, Co2+ and Cu2+ , which can complex citrate and tetracycline [40-44], have a constant 
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affect if their concentration are larger than 16, 16 and 2 µM, respectively, at 40 µM of citrate 
in EuTc-Cit. Moreover, for phosphate compounds and ions, just 280 µM of  phosphate and 8 
µM of ATP interfere. It is noted that hydrogen peroxide  (which can be probed by EuTc) does 
not affect the fluorescence of EuTc-Cit, probably because of the much weaker coordinating 
ability of H2O2 to Eu3+, and of different stoichiometry (molar ratio of Eu:Tc is 1:1 here, but 
the optimal molar ratio of EuTc is 3:1 when probing H2O2). 
TABLE 4.2. INTERFERENCES OF COMMONS SUBSTANCES FOR EUTC-CIT 
(interference is maximally -10 % of initial fluorescence intensity) 
EuTc-Cit 
 Maximum tolerable concentration 
ratio ( compare with 40 µM of 
citrate) 
NO3-, F-, Br-, I-, SO42-, HCO3-, NH4+, Na+, K+  1000 
L-glutamic acid, glucose, glycerol, succinate, acetate  500 
Cd2+, L-malate, lactate  200 
ascorbate  120 
tartrate, fumarate, ketoglutarate, pyruvate  50 
AMP  40 
Mg2+  32 
Ca2+, uric acid, malonate  20 
D-malate,   16 
NADH  10 
phosphate  7 
isocitrate  4 
Fe3+, Zn2+, oxaloacetate  3 
ADP  1 
Co2+, Ni2+  0,4 
ATP  0,2 
Cu2+  0,05 
HSA  (1.56 mg/mL) 
 
Chapter 4. Fluorescence Determination and Imaging of Citrate 
70 
0 200 400 600 800
102
103
104
co
un
ts
decay time (µs)
 EuTc (50 µM)
 + citrate (4 µM)
 + citrate (16 µM)
 + citrate (100 µM)
 
Figure 4.8. Lifetime assay of citrate. 
 
4.2.4. Quantitative Assay of Citrate  
4.2.4.1. Lifetime based assay 
Decay time can be used as a parameter for citrate assay, e.g. by time-correlated single 
photon counting (TCSPC) as shown in Fig. 4.8.  
The decay time is increasing with the increase of citrate concentration in EuTc. The 
decay times of three components from different concentrations of citrate in EuTc are 
compiled in Table 4.3. The relative amplitudes of third component from each samples at ~ 
100 µs increase from 4 % on going to ~ 50 % with concentration of citrate increasing, at last it 
becomes stable in 100 µM of citrate in EuTc. In contrast to τ3, the relative amplitudes of first 
component is decreasing with the increase of citrate concentration. 
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Figure 4.9 .Calibration curve citrate via steady-state fluorescence intensity. 
 Concentration of EuTc is 50 µM. F and F0 are fluorescence intensities of EuTc in presence and 
absence citrate. 
TABLE 4.3. THE DECAY TIME ASSAY OF EUTC-CIT 
(Fitting function: 3-exponentail) 
Samples No. Decay (µs) Rel. Amplitude (%) Av./µs 
τ1 8.3 40.7 
τ2 24.6 55.4 EuTc(50 µM:50 µM) 
τ3 123.4 4.0 
44.3 
τ1 13.8 59.1 
τ2 29.9 34.7 EuTc-Cit (4 µM) 
τ3 115.9 6.2 
48.7 
τ1 17.0 38.0 
τ2 58.7 35.3 EuTc-Cit (16 µM) 
τ3 106.3 26.8 
78.2 
τ1 15.9 13.4 
τ2 61.2 35.5 EuTc-Cit (100 µM) 
τ3 96.3 51.2 
83.6 
τ1 15.1 12.5 
τ2 58.5 32.7 EuTc-Cit (150 µM) 
τ3 95.0 54.8 
83.4 
 
4.2.4.2. Conventional steady-state fluorescence assay 
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In contrast to TCSPC, which is usually tedious and requires expensive instrumentation, 
conventional steady-state fluorescent spectroscopy is widely used. For citrate assay, the 
dynamic range is from 8x10-7 to 4 x 10-5 M, with  4 x 10-7 M of the limit of detection (defined 
as 3σ /slope) and the relatively small error bar (for n=3) in Fig. 4.9. 
4.2.4.3. Time-resolved  fluorescence assay 
The time-resolved fluorometry has also been studied for citrate assay. This method 
records the fluorescence intensity after a lag time, so it can eliminate the background 
fluorescence. The effect of different lag times on F/F0 of the EuTc system in absence and in 
presence of citrate is shown in Fig 4.10(a). F/F0 increases on going from 0 µs to a 100 µs lag 
time. The F / F0 value reaches a maximum at a lag time from 100 to 150 µs and decreases 
after 150 µs lag time. This is in accordance with the decay profile of EuTc-Cit because the 
main component in the decay profile of EuTc-Cit has a 95 µs decay time. Therefore, most of 
the increase in fluorescence is detected if the integration time window is opened after a lag 
time of 100 µs. 
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figure 4.10. (a) Fluorescence of F /F0 in EuTc-Cit at different lag time, with a 40 µs integration 
time  (b) Fluorescence ( F /F0 ) in EuTc-Cit at different integration time, with 100 µs. F and F0 
are fluorescence intensity of EuTc(50 µM) in presence and absence citrate (150 µM ). 
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Figure.4.11. Imaging of citrate in EuTc (50 µM) probe. Steady-state imaging, one window for 0-
50 µs;. citrate concentrations (from left to right) are 0, 0.16, 0.4, 1.0, 1.6, 4.0, 10.0, 16.0, 20., 
40.0, 60.0 and 80.0 µM, respectively 
The integration time is defined as the length of the time period, the detector is exposed to 
the emission light. Fig. 4.10(b) shows the effect of the integration time on F / F0, while 100 µs 
lag time was employed. If the integration time is increased from 20 µs to 200 µs, F / F0 
decreases slowly. Considering that the major component of the luminescence decay of  
EuTc-Cit, a 40 µs integration time was regarded to be appropriate. Obviously,  the integration 
time is not really critical. 
The time-resolved assay of citrate  with a lag time of 100 µs and integration time of 40 
µs has a dynamic response between 1.6 x 10-7 and 5.6 x 10-5 M, with a detection limit (defined 
as 3σ /slope) of 6.0 x 10-8 M of  citrate. 
4.2.4.4. Imaging  
Two imaging schemes were employed for the determination of citrate, the first is 
conventional steady-state imaging in Fig. 4.11. It shows significant fluorescence changes 
while EuTc probe was added in the different concentrations of citrate. But the images are 
greatly affected by fluctuations of the light source and light scatter and leaded to the pictures 
of substantial heterogeneity.  
The second is rapid lifetime determination (RLD) imaging  [45-47] as shown in Fig. 
4.12. The principle of RLD is shown in Fig. 4.12(a), two imaging windows are used in the 
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Figure 4.11.(a) Scheme of rapid lifetime detection (RLD) imaging , (b) RLD for citrate in EuTc 
(50 µM) two windows from 100-180 µs and from 200-240 µs. citrate concentrations (from left to 
right) are 0, 0.16, 0.4, 1.0, 1.6, 4.0, 10.0, 16.0, 20., 40.0, 60.0 and 80.0 µM, respectively. 
decay period of the fluorophore. The LED pulses lasted from 0-50 µs. Image 1 was recorded 
after a time lag of 50 µs (gating time t1: 100-180 µs) and image 2 after a time lag of 150 µs 
(gating time t2: 200-240 µs). The ratio is calculated to: 
                             RRLI = (RLD 1) / (RLD 2)                                              (Equation 4-1) 
The RLD images require that the fluorophore has a microsecond scale lifetime, EuTc-Cit 
is suitable for this approach. In contrast to steady-state imaging, RLD (Fig. 12 b) offers better 
homogeneity since the lifetime is relatively independent of the scattering and fluctuations in 
the intensity of the light source and advantages in terms of signal generation and of excluding 
artifacts including local inhomogeneities of the concentration of fluorescent probes. 
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4.2.4.5. Comparison with other chemical methods for citrate assay 
The main methods for citrate assay are summarized in Table 4.4. These approaches 
focus on amperometry, colorimetry, fluorescence and chemiluminescence: (a) most of them 
usually need two or three reaction steps by enzymes or catalysts to yield products which have 
significant properties suitable for determination. These experimental processes are tedious 
and some side reactions occur. (b) enzyme for citrate assay via NADH as monitor, which has 
been commercializad, can be used in colorimetry or fluorometry. But its sensitivity is still 
lower than that of the EuTc-Cit method. (c) synthetic receptor is also used to recognize 
citrate, but its selectivity and sensitivity is not good enough. (d) EuTc-Cit method has simple 
reaction step and facilitation manipulation. It can be used in time-resolved fluorescence 
detection, which can suppress the background fluorescence, for improve selectivity and 
sensitivity to obtain a low the limitation of detection.  
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TABLE 4.4. MAIN CHEMICAL ANALYTICAL APPROACHES OF CITRATE 
 methods principle linear range LOD ref. 
1 
enzyme 
(spectrophotometry) 
citrate  → lyasecitrate oxaloacetate + acetate 
oxaloacetate + NADH + H+  → asedehydrogenmalic malate + NAD+ 
 0.02 µmol 48 
2 enzyme-solid same method 1. (spectrophotometry) 1-20 mg L-1  49 
3 amperometry 
Citrate  → ++ 2,2,. ZnMglyasecitrate acetate + oxaloacetate 
oxaloacetate  → ++ 2,2,. MnMgasedecarboxylteoxaloaceta pyruvate + CO2 
pyruvate + H3PO4 + O2  → ++ TPPFADMnMgoxidasepyruvate ,,2,2,. acetylphosphate + CO2 + H2O2  
0.25-5.00 mM  50 
4 
amperometry 
(flow injection) 
same method 3 0.015-0.5 mM  51 
5 potentiometry polymeric membranes + quaternary ammonium ion exchanger  5x10-5 M 52 
6 chemiluminescence 
Fe(III)-citrate →hv Fe2+ + CO2 
luminol + O2 + 2HO-  → +2Fe 3-aminophthalate + N2 + 2H2O + hν 
2.0x10-7-1.0x 10-4 M  53 
7 chemiluminescence Ru(bpy)32+ +citrate + Ce4+ → [Ru(bpy)32+]* →  Ru(bpy)32+ + hν 0.38-38 µg mL-1 0.1 µg mL-1 54 
8 spectrophotometry 2,4-diaminophenol + H2O2
 → )( IIIFe  2,4-diaminophenol (dimer) + O2 + H2O 
citrate as inhibitor, citrate + Fe(III)→ Fe(III)-Citrate complex 
0-1000 mg L-1 0.96 mg L-1 55 
9 colorimetry 
Fe(III)-citrate →hv Fe(II) + CO2 
Fe(II) + 1,10-phenanthroline → [Fe(phen)3]2+ 
1-120 µg L-1  56 
10 colorimetry competitive indicator for host – guest complexes  55 µM 57 
11 ion chromatography polymeric anion exchange column, trimesic acid mobile phase   1-12 µg 0.26 µg 58 
12 fluorometry, imaging europium-tetracycline-citrate  (this method) 1.6x10-7-5.6x10-5M 6.0 x10-8M  
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Figure 4.12. Comparison with different tetracyclines and ratio in Eu-xTc-Cit 
xTc: tetracycline hydrochloride (Tc), chlortetracycline hydrochloride (clT), rolitetracycline 
hydrochloride (rT),oxytetracycline hydrochloride (oxT), demeclocycline hydrochloride (deT), 
doxycycline hydrochloride (doT), minocycline hydrochloride (miT), meclocycline sulfosalicylate 
salt (meT). molar ratio is Eu/xTc, concentration of citrate and xTc is 100 µM and 48 µM, 
respectively, concentration of Eu3+  is changed according to ratio. 
 
4.2.5. Different Kinds of Tetracyclines in Eu-xTc-Cit 
Further studies were performed for different tetracycline derivatives as shown in Table 
4.5. 
According to Fig. 4.12, it concludes that a) among tetracycline analogs, the fluorescence 
intensity of oxytetracycline, tetracycline and rolitetracycline chelating europium ion with 
citrate are strong, that of demeclocycline, doxycycline, chlortetracycline and meclocycline 
sulfosalicylate are medium, and that of minocycline is very weak. These refer to their 
structures of molecule. Obviously, it is favorite that OH groups in R3 of tetracyclines.  
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TABLE 4.5. THE STRUCTURES OF FAMILY OF TETRACYCLINE           OH O OH O
NHR6
O
OH
R5R2 R3R1
OH
R4
 
No. Chemicals R1 R2 R3 R4 R5 R6 
1 tetracycline H CH3 OH H (CH3)2N- H 
2 chlortetracycline Cl CH3 OH H (CH3)2N- H 
3 rolitetracycline H CH3 OH H (CH3)2N- N  
4 oxytetracycline H CH3 OH OH (CH3)2N- H 
5 demeclocycline Cl H OH H (CH3)2N- H 
6 doxycycline H CH3 H OH (CH3)2N- H 
7 minocycline (CH3)2N- H H H (CH3)2N- H 
8 meclocycline sulfosalicylate salt Cl =CH2 \ OH 
COOH
OHSO3-(CH3)2N
+
H
 
H 
 
tetracycline hydrochloride (Tc), chlortetracycline hydrochloride (clT), rolitetracycline hydrochloride (rT), oxytetracycline hydrochloride (oxT), demeclocycline hydrochloride (deT), 
doxycycline hydrochloride (doT), minocycline hydrochloride (miT), meclocycline sulfosalicylate salt (meT) 
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However, R1 group except H is hindrance, for example, R1 = Cl- in demeclocycline, and 
(CH3)2N- in minocycline. But R6 = group was no influence on the coordination of Tc and 
Eu3+, such as R6 = 
N
 in oxytetracycline. b) the optimal molar ratio of Eu:Tc is at 1:1 
regardless of any tetracycline. c) The orders of fluorescence intensity  of coordination of Tc 
and Eu3+ with citrate are different. For example, at ½ (or 0.5/1) of  mole ratio of Eu3+:Tc, the 
order is oxytetracycline > rolitetracycline > tetracycline > doxycycline > demeclocycline > 
meclocycline sulfosalicylate > chlortetracycline > minocycline. But at 2:1 molar ratio, the 
order is change, tetracycline > oxytetracycline > rolitetracycline > demeclocycline > 
doxycycline > chlortetracycline > meclocycline > minocycline. These knowledge on 
structures will greatly benefit further studies, especially the optimization of Eu-xTc 
fluorescence probes for citrate. 
4.3. Conclusion 
A europium derived fluorescent probe for the measurement and visualization of citrate is 
first time presented. Besides a straightforward direct detection using a simple reagent and 
without the need for multi-enzyme assays, many lifetime and imaging techniques are utilized 
in this system. This probe is simple to prepare, stable both in solution and in solid , and 
compatible with the blue laser diodes. It will be most useful for monitoring citrate-related 
bioprocesses.  
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4.4. Experimental Section 
4.4.1 Reagents 
Tri-sodium citrate dihydrate and other inorganic salts were obtained in analytical purity 
from Merck unless otherwise stated. All solutions were prepared in 10 mM 4-(2-
hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) buffer of pH 8.0 (Sigma-Aldrich, 
Deisenhofen, Germany) unless otherwise specified. Europium(III) trichloride hexahydrate 
was from Alfa Products, tetracycline hydrochloride from Sigma.  
The EuTc standard solution was obtained by dissolving Eu3+ chloride and tetracycline 
(each in 0.5 mM concentration) in 10 mM HEPES buffer of pH 8.0. This reagent is stable for 
at least 2 months if stored at 4 °C in the dark.  
4.4.2. Apparatus 
Absorption spectra were acquired on a Cary WinUV photometer. Fluorescence studies of 
the effect of citrate on spectra the EuTc were performed on an SLM AB2 luminescence 
spectrometer. Fluorescence intensity was acquired on either a Fluoroskan Ascent micro titer 
plate reader or on a Tecan GENios+ micro plate reader. The excitation/emission filters were 
set to 405/620 nm, or 405/612 nm respectively. The 96-well black, transparence, flat bottom 
microtiter plates for imaging were obtained from Greiner Bio-One GmbH (Frickenhausen, 
Germany; www.greiner-lab.com). The luminescence lifetimes of different concentration of 
citrate in EuTc were determined with a pulsed 392-nm laser  and an H5783-P04 PMT detector 
with multiphoton-counting board in a multipass cuvette. Circular dichroism (CD) spectra 
were performed on JASCO model J – 710 spectropolarimeter (www.jasco.de). DMR 
fluorescence microscopy is from Leica (www.light-microscopy.com) 
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4.4.3. Fluorescence Microscopic Observation of Solid form EuTc-Cit 
Efforts have been made to crystalize EuTc-Cit. 20 µL of EuTc (50 µM) in citrate (150 
µM) forms a drop on the cover slide, which is hung over the reservior in which includes 40 % 
(v/v) polyethylene glycol 400. After one week, a thin solid member (instead of crystal) is 
observed under fluorescence microscopy. Two photos of solid EuTc-Cit were obtained on a 
Leica DMR fluorescence microscopy. One is in UV light with objective lens of PL 
FLUROTAR (cut off 470 nm) at 4.0 s exposure time and 4.1 gain; the other in white light 
with objective lens of  N PLAN at 45.8 ms exposure time and 4.1 gain. 
4.4.4. RLD Imaging 
Imaging set-up was as described in section 3.4.6. Scheme of RLD with two windows of 
fluorescence detection at 100-180 µs and 200-240 µs are recorded. The manipulation and 
calculation of images, such as the rotation and crop of the images, the subtraction of the dark 
image (blank, without illumination) from the fluorescent image respectively, the ratio of the 
images and filtration of the background noise, were done by a self-developed program based 
on Matlab (6.1, Mathwork, Natick, MA, USA). 
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Figure 5.1. The Krebs cycle (adapted from. Berg, J. M ref.[2]) 
Chapter 5. Fluorescence Imaging and Detection of Main 
                  Intermediates in the Krebs Cycle 
5.1. Introduction 
The Krebs cycle [1, 2] (Fig. 5.1) is a key series of metabolic reactions in aerobic cellular 
respiration, occurring in the mitochondria of animals and plants. It is the central metabolic 
hub of the cell not only for harvesting chemical energy [3, 4], but also for building the basic 
blocks of amino acids, nucleotide bases, porphyrins and others [5-7]. 
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There are many intermediates in the Krebs cycle had been studied. By exploring the 
interactions between the Krebs cycle and other metabolism systems [8-10], intermediates are 
still medium. The most of studies of the Krebs cycle have been developed basically through 
isotropic labels [11-13] especially for the mechanism research. The main intermediates in the 
Krebs cycle, such as citrate, isocitrate, α-ketoglutarate (KG), succinate, fumarate, L-malate 
and oxaloacetate (their structures are in Fig. 5.1), are usually absent of significant physical 
and chemical properties suitable for direct non-radioactive determination, and therefore the 
Krebs cycle is difficult to visualize and to detect directly. Besides separative chromatography 
[14-16] and electrophoresis [17-19], enzyme or multi-enzymatic methods [20-23] are mostly 
employed by coupling with reactions involving NADH. These methods always depend upon 
the change of NADH [24-26] as a monitor to detect reactants or products. But the 
disadvantages of detection through NADH in biosamples are obvious: short decay times, UV 
excitation at 355 nm and complicated reaction processes.  
Here, a europium derived fluorescent probe has been used for the detection and 
visualization of main intermediates. The method is based on the finding that the weakly 
fluorescent europium-tetracycline (EuTc) [27-29] can reversibly associate with intermediates 
to form differently fluorescent europium-tetracycline-ligands (EuTc-L) at neutral pH. As 
these complexes have the merits of lanthanide fluorescence, time-resolved fluorescence 
detection can be used. Fluorescence imaging is applied for the visualization of intermediates. 
In addition, the stepwise determination of the formation and decomposition of intermediates 
can be performed via the kinetic fluorescence changes.  
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Figure 5.2. Spectra of EuTc-L complex. Eu3+: 50 µM, Tc: 50 µM L:150 µM 
 
5.2. Results and Discussion 
5.2.1. Characterization of EuTc Complexes with Main Intermediates 
5.2.1.1. Absorbance and fluorescence spectra 
The absorption and fluorescence spectra of the EuTc-L systems are shown in Fig. 5.2. 
The maximal absorbances of EuTc-L are from 381 to 408 nm, similar to that of EuTc In 
contrast, the fluorescence intensity of the emissions of EuTc-L are stronger than that of EuTc 
from 615 to 619 nm. These intermediates can act as polydentate ligands and thus may be 
expected to form ternary complexes with EuTc. The coordination with Eu3+ involve  oxygen 
atoms from carboxyl and hydroxy group, probably resulting in formation of 5-, 6-, or 7-
member ring with Eu3+ [30-32]. Different molecule structures lead to different fluorescence 
intensities (Fig. 5.2), as well as in decay times and quantum yields (Table 5.1)  
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TABLE 5.1. THE DECAY PROFILES  AND QUANTUM YIELD OF EUTC-L 
Samples a) Components b) Decay (µs) 
Rel. Amplitude 
(%) 
Av.(µs) QY(%)c) 
τ1 8 40.7 
τ2 24 55.4 EuTc 
τ3 123 4.0 
44 0.4 
τ1 15 12.5  
τ2 58 32.7  EuTc-Cit 
τ3 95 54.8  
83 3.2 
τ1 16 57.4  
τ2 40 27.6  EuTc-iCit 
τ3 111 15.0  
66 0.7 
τ1 8 40.5  
τ2 21 56.1  EuTc-KG 
τ3 112 3.4  
37 0.4 
τ1 7 36.3  
τ2 21 57.4  EuTc-Suc 
τ3 88 6.2  
38 0.4 
τ1 8 28.0  
τ2 22 49.3  EuTc-Fum 
τ3 90 22.8  
63 0.5 
τ1 17 53.3  
τ2 61 24.2  EuTc-Mal d) 
τ3 109 22.6  
77 0.8  
τ1 13 14.7  
τ2 49 60.1  EuTc-Oxa 
τ3 71 25.1  
56 1.4 
 
a) Eu3+: 50 µM, Tc: 50 µM, for the purpose of the Krebs cycle study, only 150 µM of L (ligand) is used here. 
b) Fitting function: 3-exponential decay    
c) tris (2,2’-bipyridyl) dichlororuthenium(II) hexahydrate as the reference, ref [33] 
d) In this case, the concentration of L-malate for EuTc is not saturated. 
 
 
5.2.1.2. Fluorescence Decay times and Quantum Yields 
The decay profiles of EuTc-L complexes, as obtained through TCSPC, can be fitted into 
a three-component model as summarized in Table 5.1. The  quantum yields of EuTc-Cit and 
EuTc-Oxa show higher than that of other intermediates. For decay times, the average lifetime 
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of EuTc-Cit and EuTc-Mal are longer than others. EuTc-iCit, EuTc-Fum and EuTc-Oxa have 
a lifetimes longer than that of EuTc, while EuTc-Suc and EuTc-KG are almost same as EuTc. 
As KG and succinate cannot effectively form complexes with Eu3+, no significant fluorescent 
intensity and lifetime enhancement are expected and indeed observed. Decay times of 
different components for EuTc-L are important in the time-resolved and RLD imaging. 
Furthermore, by choosing different lag times for “gated” detections, different intermediates 
can be determined in different time windows. 
5.2.2. Imaging for the Krebs Cycle 
Imaging [34-36] as a potential “mapping” technique has been used to show the Krebs 
cycle as in Fig. 5.3. From Fig. 5.3(a), the different Krebs cycle intermediates in steady-state 
imaging have been observed at time window from 0 – 50 µs according to their fluorescence 
intensity. The fluorescence of EuTc-Cit is significantly higher than others, while those of 
succinate and KG are almost the same as the background. The order of the rest is oxaloacetate 
> malate > isocitrate.  
RLD imaging, which has been discussed in section 4.2.4.4, was also employed to depict 
the Krebs cycle. Two windows from 100 to 150 µs and from 160 to 210 µs were imaged in 
Fig. 5.3(b), the dramatic fluorescence changes of EuTc-L complexes were observed. Due to 
different decay times of EuTc-L in Table 5.1, the relative ratios (RRLD) of the integrations 
between two windows for EuTc-L are also different. The relative ratios of L-malate and 
fumarate in EuTc obviously increase, however, that of oxaloacetate is significantly decreasing 
to a level almost as KG. RLD imaging can further explain the possibility of distinguishing 
intermediates by the lifetime-based fluorescence. 
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(a)
 
 
 
(b)
 
 
 
Figure 5.3. Fluorescence imaging of main intermediates in the Krebs cycle. (a) steady-state imaging, 
one window form 0-50 µs; (b) rapid lifetime determination (RLD) imaging, two time windows from 
100-150 µs and from 160-210 µs. Intermediates (150 µM) were added in EuTc (50 µM) 
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5.2.3. Conversions Between Intermediates in the Krebs Cycle 
5.2.3.1. Stepwise visualization of decomposition of citrate 
The characteristics of the EuTc complexes with main intermediates of the Krebs cycle 
have made it possible for the stepwise visualization of decomposition of citrate. Oxaloacetate, 
L-malate and fumarate can be produced according to the following enzymatic reactions (Eq. 
5-1, 5-2, 5-3), 
citrate
CL
  oxaloacetate + acetate                               (Equation 5-1) 
oxaloacetate + NADH + H+   
MDH
 L-malate + NAD+                (Equation 5-2) 
L-malate  
FM
  fumarate +H2O                              (Equation 5-3) 
0 25 50 75 100 125
0
1
2
3
4
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MDH
CL
citrate
blank
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Figure 5.4. Kinetic curve of the formation and stepwise decomposition of EuTc-Cit complex. 
Blank solution including 200 µL of 0.5 mM EuTc and 60 µL of 4.8 mM of NADH in 1.70 mL of 
HEPES buffer, then 40 µL of 2 mM citrate, 70 µL of 3.4 U/mL citrate lyase (CL), 50 µL of  
1588 U/mL malic dehydrogenase (MDH) and 80 µL of 618 U/mL fumarase (FM) were 
added, respectively. 
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Citrate lyase (CL), malic dehydrogenase (MDH) and fumarase (FM), respectively, were 
employed to catalyze these reactions. Fig. 5.4 indicates the stepwise processes via 
fluorescence: the fluorescence of a blank solution, composed of EuTc and NADH only, is 
stable over time. (In this experiment, NADH does not interfere the fluorescence of EuTc and 
EuTc-Cit because they have different emissions and excitations.) While adding citrate, the 
fluorescence increases due to the formation of the EuTc-Cit complex. After fluorescence of 
EuTc-Cit reached a plateau, CL, MDH and FM were added, respectively. Fluorescence 
decreases step by step (in three stages), thereby indicating the complete consumption of 
citrate and formation of EuTc-oxaloacetate, EuTc-malate and EuTc-fumarate, respectively. 
This experiment manifests that (a) EuTc-L acts as a reversible fluorescent probe, and the 
change of concentrations of the main intermediates of the Krebs cycle can be directly 
monitored via fluorescence, (b) Despite the fact that the reaction of Eq 5-2 can also be 
determined by the NADH, the dual simultaneously fluorescent measurements by EuTc-
oxaloacetate and NADH have indicated the former is much more sensitive (see section 
5.2.4.2). (c) The stepwise decompositions of citrate, oxaloacetate, and L-malate can be clearly 
visualized through their complexes with EuTc. NADH can only indicate one of the 
decomposition steps or the overall changes without the capability of stepwise indication of the 
reactions. 
 
5.2.3.2. Formation of citrate in the Krebs cycle 
The application and specificity of EuTc-L system for the Krebs cycle is further explored 
by the kinetic change in the intermediate steps in Eq.5-4 and Eq.5-5, which are usually 
considered as the last step and the first step in the Krebs cycle. 
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        L-malate + NAD+
MDH
oxaloacetate + NADH + H+                                ( equation 5-4) 
                      ∆G°´ =  +29.7 kJ mol-1        
      Acetyl CoA + oxaloacetate + H2O 
CS
citrate + CoA + H+                      (equation 5-5) 
                                                                               ∆G°´ =  -31.4 kJ mol-1             
Unlike the other steps in the Krebs cycle, the standard free energy of Eq. 5-4 is 
significantly positive, the formation of citrate from malate is possible when coupled with Eq. 
5-5, driven by the utilization of the products oxaloacetate by citrate synthase (CS) and NADH 
by the electron-transport chain. As shown in Fig. 5.5, the fluorescence signal of blank with L-
malate, MDH, acetyl CoA, CS and EuTc is stable and low (although a litter bit higher than 
EuTc) over time, no reaction happened. The products in Eq. 5-4, and 5-5, NADH and CoA do 
0 50 100 150 200
1
2
3
4
Blank
CL
NAD+
F
t / min
 
Figure 5.5. Kinetic curve of the formation and  decomposition of citrate. 
Blank including 0.2 mL of  0.5 mM EuTc, 0.4 mL of 0.5 mM L-malate, 0.16 mL of  9.9 U/mL 
MDH, 0.16 mL of 1 U/mL CS, 0.16mL of 0.23 mM acetyl CoA  and  0.8mL of 10 mM HEPES 
buffer at 8.0 pH in cuvette , plus 54 µL of 14 mM NAD+,  then add 55 µL of  4.3 U/mL CL when 
the maximum fluorescence was reached. 
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not introduce the fluorescence change. After the addition of NAD+, the whole reaction from 
Eq.5-4 to Eq. 5-5 is initiated and resulted in the production of citrate, consequently the 
increase of the fluorescence due to the formation of the EuTc-Cit system. To further indicate 
the specificity of the EuTc-L system, CL is used to testify the existence of citrate in Eq. 5-6. 
                           citrate
CL
  oxaloacetate + acetate                                     (equation 5-6) 
The addition of CL causes the decrease of citrate and a drop of the fluorescence. This 
experiment has realized (a) citrate was product by the pathway in the Krebs cycle, this process 
can be kinetically monitored via fluorescence. (b) Dual fluorescence determinations for EuTc-
Cit and NADH can also be simultaneously monitored, they depict the reaction processes of 
Eq. 5-4 and Eq. 5-5, respectively. 
5.2.4. Fluorescence Detection of Main Intermediates in the Krebs Cycle 
5.2.4.1. Time-resolved fluorescence assays 
As the different decay times of EuTc-L, the discrimination of intermediates can be 
performed in different time windows. In steady-state fluorescence measurement (with 0 µs  
lag time in Fig. 5.6), the order of the normalized intensity [defined as (F – F0) / F0] is EuTc-
Cit > EuTc- Oxa > EuTc-Ma > EuTc-iCit > EuTc-Fum > EuTc-Suc ≈ EuTc-KG ≈ EuTc. 
Gating obviously can be used to fine tune between selectivity and sensitivity. On increasing 
the lag time from 0 to 100 µs, the normalized intensity of all species is increased (Fig. 5.6.) 
except for KG. On increasing the lag time to 250 µs, oxaloacetate is widely suppressed and 
citrate is reduced by 40 %, while isocitrate, fumarate and malate, remain much less affected. 
Obviously, L-malate and oxaloacetate can be nicely discerned. By comparing citrate with 
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isocitrate, it is noted that decay times of the main components of EuTc-Cit (95 µs) and EuTc-
iCit (16 µs) are quite different (Table 5.1).  
 
Figure 5.6. The relative fluorescence intensities of EuTc-L complexes at different lag times.  
Concentration of EuTc is 50 µM, L: citrate, isocitrate, ketoglutarate, succinate, fumarate, L-malate 
and oxaloacetate is 150 µM. F0 and F are fluorescence intensities of EuTc and EuTc-L complex. 
 
 
It should be emphasized that the main intermediates can be sensed and imaged directly 
through their complexes with EuTc, and that no enzymes or multi-enzyme systems are 
needed. However, assays for other intermediates have to exclude any interference by citrate. 
5.2.4.2. Dual fluorescence detection the decomposition process of oxaloacetate 
Dual fluorescence measurement here refers to detection of two fluorophores which have 
different excitation wavelengths and emissions. This method not only offers multi-parameters 
for analytes, but also benefits for monitor of the kinetic processes of reaction. In the 
decomposition of oxaloacetate (Eq. 5-2), the fluorescence intensities of EuTc-Oxa and NADH 
were detected, the excitation and emission of EuTc-Oxa are at 405 and 620 nm, the respective 
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data for NADH are at 355 and 460 nm. The fluorescence kinetic changes of EuTc-Oxa and 
NADH express the oxaloacetate consumed by MHD catalytically. The time trace of EuTc-
Oxa is Y = 7.73 + 0.38 X (R = 0.97), that of NADH is Y = 162 + 0.14 X (R = 0.96), Y and X 
denote corrected fluorescence intensity and time. But the former method is more sensitive 
because of steeper slope. 
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Figure 5.7. Dual fluorescence determination of the decomposition of oxaloacetate via the fluore-
scence changes of EuTc-Oxa (exc: 400 nm, em: 620 nm) and NADH (exc: 355 nm, em: 460 nm). 
Concentration of EuTc, oxaloacetate and NADH are 48, 96 and 185 µM, respectively. The activity of 
MDH is 7 U/mL. F and F0 are the fluorescence intensity of EuTc-Oxa and NADH at t and 0 min 
 
 
5.3. Conclusion 
The time-resolved fluorescence detection and imaging of main intermediates of the 
Krebs cycle has been made possible for the first time. Some lifetime and imaging techniques 
are utilized in this system as the discrimination of their characteristics of fluorescence. The 
process of the stepwise decompositions of intermediates, such as citrate, isocitrate, 
oxaloacetate and L-malate can be also directly visualized. This probe will be widely used in 
other bioassays. 
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5.4. Experimental Section 
5.4.1. Reagents 
Citrate lyase (EC: 4.1.3.6, from Enterobacter aerogenes), citrate synthase (EC: 4.1.3.7, 
from porcine heart), mitochondrial malic dehydrogenase (EC: 1.1.1.37, from porcine heart), 
and fumarase (EC: 4.2.1.2 from porcine heart) were from Sigma and used without further 
purification.  
Tri-sodium citrate dihydrate, α-ketoglutaric acid (α-oxoglutaric acid), fumaric acid, di-
sodium succinate and other inorganic salts were obtained in analytical purity from Merck 
unless otherwise stated. Ds-isocitric acid, oxaloactic acid, L-sodium malate were in analytical 
purity from Sigma-Aldrich. All solutions were prepared in 10 mM 4-(2-hydroxyethyl) 
piperazine-1-ethanesulfonic acid (HEPES) buffer of pH 8.0 unless otherwise specified. 
Europium(III) trichloride hexahydrate was from Alfa Products, and tetracycline hydrochloride 
from Sigma.  
The EuTc standard solution was obtained by dissolving Eu3+ chloride and tetracycline 
(each in 0.5 mM concentration) in 10 mM HEPES buffer of pH 8.0. This reagent is stable for 
at least 2 months if stored at 4 °C in the dark.  
5.4.2. Apparatus 
Absorption spectra were acquired on a Cary WinUV photometer. Fluorescence studies of 
the effect of intermediates (L) in the Krebs cycle on the EuTc spectra were performed on an 
SLM AB2 luminescence spectrometer. Fluorescence intensity (steady-state and time-gated) 
were acquired on a Tecan GENios+ micro plate reader. The excitation/emission filters were 
set to 405/612 nm respectively. The 96-well black, transparence, flat bottom microtiter plates 
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for imaging were obtained from Greiner Bio-One GmbH. The decay times of EuTc-L were 
detected with a pulsed 392-nm laser and an H5783-P04 PMT detector with multiphoton-
counting board in a multipass cuvette. Data were processed with the FluoFit. Dual 
fluorescence detection, EuTc-Oxa (excitation is at 405 nm, emission is at 620 nm) and NADH 
(excitation is at 355 nm, emission is at 460 nm) were simultaneously were performed in 
FLUOstar OPTIMA (BMG LABTECH, Offenburg, Germany, www.bmglabtech.com). 
Imaging data were evaluated by a self-developed program based on Matlab (6.1, Mathwork, 
Natick, MA, USA) 
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Figure 6.1. Sterochemistry of L-/ D-malate. H atom (cyan), carbon atom (grey),  
and oxygen atom (red). The specific optical rotation of malate : [ ]Dα  -2.3°  
Chapter 6. Chiral Fluorescence Discrimination  
                   of L-/D-Malate 
6.1. Introduction  
Chiral discrimination is of central importance in the field of molecular chirality. It is a 
key technology in the molecular elucidation of the processes of chemical biology [1], in the 
characterization and optimization of new therapeutic drugs [2, 3], as well as in the 
development of sensory agents for chiral biological molecules.  
Fluorescence for chiral recognition [4-8] is known for over 20 years, especially as an 
interesting topic in supramolecular chemistry. However, most of them so far has been 
confined to synthetic receptors in organic solvents or water-organic solvent mixtures. 
Lanthanide complexes [9, 10] have been widely utilized in chiral discrimination based on 
chiroptical scheme (such as circular dichroism [11-13] and circular polarized luminescence 
[14-16]), nuclear magnetic resonance [17-19] and in mass spectroscopy [20-22]. But none 
research based on lanthanide fluorescence intensity and lifetime is reported now.  
Malates are optically active α–hydroxy acids that exist abundantly in nature [23] and 
serve as convenient starting materials for the synthesis of homochiral compounds [24]. Chiral 
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discrimination and resolution of malates and other hydroxy acids are mostly achieved through 
HPLC [25-28] or electrophoresis [29-31]. Only a few fluorescent methods have been reported 
based on the use of synthetic receptors in organic solvents, such as the bisbinaphthyls for 
differentiating enantiomeric mandelic acids [32]. 
Here a novel fluorescent molecular chirality sensor based on the finding that both the 
fluorescence intensity and the fluorescence decay time are quite different for ternary 
complexes formed between the europium-tetracycline complex (EuTc) [33-35] and the 
enantiomeric malates in aqueous solution at neutral pH. As a result, one can discriminate 
chiral malates by either intensity-based or decay-based fluorescence.  
6.2. Results and Discussion 
6.2.1. Fluorescent Spectra of Enantiomeric Malate in EuTc 
The different spectral characteristics of EuTc complexes with enantiomeric malates are 
shown in Fig. 6.2. The absorbances of the ternary EuTc-L-malate and EuTc-D-malate 
complexes peak both at 381 nm, with shoulders at around 405 nm. The maximal emissions of 
EuTc-L-malate and EuTc-D-malate are also similar at 619 nm and at 618 nm as the europium 
emission. Side bands are formed at 580, 591, 651, and 697 nm. The different mainband 
splittings of the two complexes result from different effects of the enantiomers on the crystal 
field [36]. The maximal capability of discrimination [(FL-F0)/(FD-F0)] for chiral malates is 
found to be 5.9 at 619 nm, where F0, FL, and FD denote the fluorescence intensities of EuTc, 
EuTc-L-malate and EuTc-D-malate, respectively. The quantum yields (QY) [37] of energy 
transfer from Tc to Eu3+ increase from 0.4% in case of EuTc to 1.7 % of EuTc-L-malate and 
0.7 % EuTc-D-malate. 
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6.2.2. Optimal Experimental Conditions 
The fluorescence of the EuTc-malate system is stable between pH 7.7 and 8.7 for EuTc-
L-malate and from 7.2 to 8.7 for EuTc-D-malate in Fig. 6.3. The acid dissociation constants 
[38] of malic acid are pKa1 = 3.4 and pKa2 = 5.1. In above-mentioned pH range, both protons 
of malic acid are dissociated, and malate dianion can readily chelate with Eu3+. On the other 
hand, tetracycline [39] (section 4.2.2) may also lose two protons in this case. A 10 mM 
HEPES buffer solution at 8.0 pH was used throughout this work. It is important to note that 
phosphate buffer may not be used since phosphate forms a complex with EuTc. 
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Figure 6.2. Absorption and emission spectra of the europium-tetracycline complex (50 µM) in 
HEPES buffer of pH 8.0 (C) in the presence of 2 mM of L- malate (A) or D-malate (B). 
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The time traces of chelation of enantiomeric malates with EuTc are shown in Fig. 6.4. 
Their fluorescent intensities reach a plateau, usually forming the stable fluorescence in 10 min 
when malate (either L-malate or D-malate).  
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Figure 6.3. The effect of pH on fluorescence intensities of EuTc (50 µM) in D-malate (160 µM) or 
L-Malate (160 µM). 
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Figure 6.4. Time trace of the chelation of  enantiomeric malate in EuTc (50 µm). 
E: Blank, EuTc, A, B, C, and D with malate are 1.6, 0.4, 0.16 and 0.04 mM, respectively. 
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Figure 6.5. The decay profiles of EuTc-L-malate and EuTc-D-malate 
(a) decay time; (b) distribution of decay time. 
Eu3+: 50 µM;  Tc: 50 µM; L-malate: 2 mM; D-malate: 2 mM 
6.2.3. Fluorescence Decay Times of EuTc-L-malate and EuTc-D-malate 
The decay profiles of the emissions of EuTc-L-malate and EuTc-D-malate are also 
different as detected by TCSPC (Fig. 6.5 a). It reveals a complex decay pattern from which 
three components can be extracted for either complex. EuTc-L-malate has components of 16 
µs (with a relative amplitude of 28 %), 78 µs (48 %) and 104 µs (24 %). The respective data 
for EuTc-D-malate are 16 µs (62%), 49 µs (35 %) and 123 µs (3 %). Obviously, the average 
lifetimes of EuTc-L-malate and EuTc-D-malate are largely different (84 and 48 µs, 
respectively). The distributions of their decay times (Fig. 6.5b) are the basis for their 
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Figure 6.6. The change of F / F0 versus lag time. F0  is the fluorescence of EuTc. F is the 
fluorescence of enantiomer malate (150 µM )in EuTc (50 µM) 
discrimination by time-resolved fluorescence. Consequently, chiral discrimination may also 
be achieved by TCSPC, despite the presentation of six decay times in a mixed solution and 
the complication of instrumentation.  
6.2.4. Optimal Lag Time for Discrimination of Chiral Malates 
As TCSPC is complex, alternatively, time-resolved (“gated”) fluorescence, which is 
experimentally easier, can be applied to chiral differentiation by measuring fluorescence 
intensity after a certain delay time, since the effect is much more pronounced for the longer 
decaying EuTc-L-malate. It is based on the selection of time-delay (lag time) before detection 
of the selected window (gate) after excitation. The difference of lifetimes of EuTc-L-malate 
and Eu-Tc-D-malate result in the different intensities in the detection windows. The effect of 
different lag times on F / F0 of the EuTc with enantiomeric malates are displayed in Fig. 6.6. 
For L-malate, the value of F/F0 increases on going from 0 µs to a 100 µs lag time with a 80 µs 
integration time, and decreases after 150 µs; for D-malate, the value of F / F0 has only a 
minimal increase up to 300 µs lag time. The changes of fluorescence intensity in different lag 
Chapter 6. Chiral Fluorescence Discrimination of L-/D-Malate 
108 
time can be explained by the distribution of decay time in Fig. 6.5 b. The most efficient 
fluorescent discrimination of enantiomeric malates is at 120 µs decay time. 
6.2.5. Fluorometric Determination of Enantiomeric Excess of Chiral Malate 
The applicability of EuTc as a fluorescent probe for chiral discrimination of malate is 
best presented in the quantitative determination of their optical purity. Steady-state 
fluorescence can be used to determine the enantiomeric excess (ee, defined as in Eq. 6-1) of a 
system in Fig. 6.7. The ee of malates is indicated by normalized fluorescence intensity 
according to (F–F0)/F0 when EuTc was added to a solution of a mixture of L- and D-malate. A 
linear relationship exists between normalized fluorescence intensity and ee.  
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Figure 6.7. Relationships between ee % of malate and fluorescence. F and F0 are the 
fluorescence intensities of EuTc (50 µM )in presence and absence of a mixture of ([L-
malate]+[D-malate]=500 µM) . 
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Figure 6.8. Imaging (2D) of enantiomer malates([L-malate]+[D-malate] = 500 µM) in EuTc 
(50 µM). (a) steady-state fluorescence imaging, window from 0-50 µs; (b) time-gated 
fluorescence imaging, window from 140-220 µs. 
 
The time-resolved fluorescence is also applied to chiral differentiation. Therefore, a 120 
µs delay time and a 80 µs integration time were chosen in order to suppress the contribution 
of D-malate to a substantial extent. Fig. 6.7 shows the resulting plot of gated fluorescence 
intensity versus ee. It is obvious that gated discrimination is more sensitive than the steady-
state fluorescence determination for ee. The linear correlation coefficients are 0.99 for both 
graphs when the total concentration is kept constant. Thus, this relationship can be employed 
and detect the optical purity of malate.  
6.2.6. Fluorescence Imaging of Enantiomeric Malates 
Fluorescent imaging is a viable tool for two-dimensional presentation (“mapping”) of 
analytes [40-43]. Here for the first time, chiral discrimination can also be accomplished 
through time-resolved fluorescence imaging. As shown in Fig. 6.8, both the steady-state and 
the time-resolved fluorescence imaging can be utilized to visualize the ee of malates. Fig. 6.8 
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Figure 6.9. Imaging (3D) of enantiomer malates([L-malate]+[D-malate] = 500 µM) in EuTc (50 
µM). (a) time-resolved imaging, one time window from 160-240 µs; (b) steady-state imaging, one 
time window from 0-50 µs; Composition of ee (%), in (b) is the same as in (a). 
(top) gives the data as a conventional fluorescence two - dimensional graph (false color), and 
Fig. 6.8 (bottom) as a time-resolved (gated) fluorescence imaging. The latter has large 
discrimination capability for enantiomeric malates. These data can also be shown as three-
dimensional graphs as in Fig. 6.9. Contrast to Fig. 6.8, the conventional and time-gated 
fluorescence imaging in Fig. 6.9 have more direct and clear expression of the relationship of 
ee % and imaging. 
This probe shows the potential to map the chiral-specific spatial arrangement of ligands 
on the surface. In addition to, the several promising features of the time-resolved fluorescence 
imaging of chiral lanthanide complex have been expressed, such as large chiral selectivity 
(which facilitates quantitative analysis) and the capability of chiral recognition independent of 
the relative concentrations of analytes and the chirality probe. 
6.2.7. Calibration Curves for L-/D-malates 
Both steady-state (Fig. 6.10 a) and time-resolved (Fig. 6.10 b) fluorometries were used 
in the determination of L-/D-malate. In the steady-state method, linear ranges of L-malate and 
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D-malate are 4.6x10-6 - 1.8x10-4 M and 4.6x10-6 – 7.3x10-5 M, with the limits of detection 
(S/N = 3) of 1.8x10-6 M and 4.6x10-6 M, respectively. In the time-gated mode, linear ranges 
are from 7.3 x 10-7 to 7.3 x 10-5 M and from 4.6 x 10-6 to 7.2 x10-5 M, with the limits of 
detection of 4.4 x 10-7 M and 4.6 x 10-6 M for L-malate and D-malate, respectively. 
Obviously, measurement of L-malate with EuTc probe by time-resolved fluorescence, 
contrast to steady-state fluorescence, can improve sensitivity and limit of detection.  
6.2.8. Origin of the Enantioselectivity  
6.2.8.1. Characteristics of chirality of EuTc-L-malate and EuTc-D-malate 
Unlike some coordinatively saturated binary europium complex [44-45], such as that of 
cryptands, calixarene ligands, EuTc itself is not coordinatively saturated and therefore is 
prone to form fairly stable ternary complexes to replace the water molecules in the inner 
coordination field, which is a quencher of the lanthanide fluorescence. As in the case of EuTc-
malates, the chirality of EuTc creates a chiral environment for the binding of enantiomeric 
malates, which would result in different fluorescence. For the characterization of the 
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Figure 6.10. Calibration curve of L-/D-malate . 
(a) steady-state fluorescence detection,  (b) time-laged fluorescence detection at 120 µs. 
Different concentration of enantiomer malates in EuTc (50 µM) probe- 
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asymmetric coordination, the circular dichroism can offer more information about ligands or 
the relationship between lanthanide and ligands.  
In Fig. 6.11 a, each enantiomeric malate has a corresponding CD peak which have 
opposite signs. Enantiomeric malates binding Eu3+ still keep the character of chiral in 
Fig.6.11b. As the chirality of Tc, this leads to the asymmetric EuTc in Fig. 6.11 c (see Section 
4.2.1.4). In Fig. 6.11 d, the values of molar CD in the positive Cotton effects of EuTc, EuTc-
L-malate and EuTc-D-malate at 242, 266 and 408 nm have a little different, other Cotton 
effects (positive and negative) are almost same except that at 222 nm, which is the opposite 
signals of CD peak from enantiomeric malates (compare with Fig. 6.11b). They can be 
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Figure 6.11. CD spectra. (a) L-malate and D-malate; (b) Eu-L-malate and Eu-D-malate; (c)Tc and 
EuTc; (d) EuTc, EuTc-L-malate and EuTc-D-malate. Concentrations of Eu3+, Tc, L-malate and D-
malate are 50 µM, 50 µM, 2 mM and 2 mM, respectively. In (a) and (b), concentration of malate 
was used to calculate the value of Mol. CD; in (c) and (d), concentration of Tc was used to 
caluculate the value of Mol. CD. 
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discriminated if the value of molar CD is calculated by the concentration of Tc. Nevertheless, 
if calculated by the concentration of malate, the CD spectra of enantiomeric malates will be 
not quite different since that can be overshadowed by the strong spectra of EuTc or Tc. It 
means that the CD spectra of EuTc or Tc can overlap that of enantiomeric malate and make 
them difficult to distinguish between L-malate and D-malate. On the other hand, it shows that 
the influences of L-/D-malate in EuTc in the ground state (S1) are not significant, the different 
fluorescence intensity may be due to their excited state, because they coordinate differently 
and the spatial orientation with the tetracycline ligand is different. 
6.2.8.2. Composition of EuTc-malate  
Job´s method has been employed for determination of the molar ratio of Eu3+:Tc :malate. 
In Fig. 6. 12 a, the maximum fluorescence intensity is reached at 1:1 molar ratio of Eu3+: Tc 
in excess malate, regardless of L-malate or D-malate. In Fig. 6. 12b, the concentration of Eu3+ 
is excess, the molar ratio of Tc:malate is approximately at 1:2. In combination of Fig. 12 a 
and b, the molar ratio of Eu:Tc:malate is 1:1:2, or (EuTc):Tc is 1:2. 
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Figure 6.12.  Job´s plot for molar rationof EuTc-malate. 
(a) ratio of Eu3+ to Tc, concentrations of malate and( [Eu3+]+[Tc]) are 333 and 83 µM; (b) ratio of Tc 
to malate, concentrations of Eu3+ and ([Tc])+[malate] are 130 and 50 µM 
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Rough estimations of the disassociation constants of EuTc-malates (EuTc:malate = 1:2) 
are calculated by the following Benesi-Hidebrand type equation [32, 46, 47] for a two binding 
site saturation.  
         
[ ]
[ ]
[ ]
[ ]MK
MB
MK
MB
F
FF
dd +
++=
−
2
2max
1
max0                                               (equation 6-2) 
where F0 and F are the fluorescence intensities of EuTc in the absence and present of malate, 
[M] is the concentration of malate, Bmax1 and Bmax2 are constants. the dissociation constants 
are Kd1 of 4 x 10-4 M, Kd2 of 3 x 10-5 M for EuTc-L-malate and Kd1 of 6 x 10-4 M, Kd2 of 7x 
10-5 M for EuTc-D-malate.  
6.2.9. Other α–Hydroxy Acids and Amino Acids 
The α-hydroxy acids lactate and tartrate were also studied. Lactate does not undergo 
significant changes in fluorescence on addition of EuTc. The enantiomeric tartrates, in 
contrast, cause an increase in fluorescence intensity of EuTc. The fluorescence intensities of 
the EuTc complex with enantiomeric tartrates at different lag time are shown in Fig. 6.13a, 
EuTc-R-tartrate and EuTc-S-tartrate have a maximum discrimination at 60 µs lag time.  
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Figure 6.13. (a)  The fluorescence intensities at different lag time for enantiomeric tartrates(5mM) in 
EuTc; (b) the calibration curves  for enantiomeric tartrates in EuTc, with 60 µs lag time.  
Concentration of Eu3+ and Tc are 50 and 50 µM. 
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The calibration curves by time-resolved fluorescence determination are depicted in 
Fig. 6.14b, but their discriminative ability [(FR–F0)/(Fs–F0)] is only 30 % of that of 
enantiomeric malate in EuTc.  
Amino acids, such as L-histidine, phenylalanine, arginine, lysine, glutamine, cysteine, 
asparagine, aspartic acid, threonine, proline, isoleucine, glutamine acid, tryptophan, serine, 
methionine, valine, leucine and tyrosine, were investigated in EuTc, but no (or only 
insignificant) fluorescence enhancements were observed. 
6.3. Conclusion 
The probe EuTc represents a novel lanthanide-based sensing probe for chiral 
discrimination using time-resolved fluorescence, and for direct imaging of enantiomeric 
hydroxy acids in aqueous solution of near-neutral pH. Chiroselective imaging is of great 
potential with respect to mapping the spatial arrangement of (chiral) ligands on solid surfaces, 
i.e. in biosensor arrays and in high-throughput screening. 
6.4. Experimental Section 
6.4.1. Reagents 
L-sodium malate, D-malic acid were obtained in analytical purity from Sigma-Aldrich. 
(2R, 3R)-(+) tartaric acid, (2S, 3S)-(-) tartaric acid, and other inorganic salts were obtained in 
analytical purity from Merck unless otherwise stated. All solutions were prepared in 10 mM 
4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) buffer of pH 8.0 unless 
otherwise specified. Europium(III) trichloride hexahydrate was from Alfa Products, and 
tetracycline hydrochloride from Sigma.  
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The EuTc standard solution was obtained by dissolving Eu3+ chloride and tetracycline 
(each in 0.5 mM concentration) in 10 mM HEPES buffer of pH 8.0. This reagent is stable for 
at least 2 month if stored at 4 °C in the dark. 
6.4.2. Apparatus 
Absorption spectra were acquired on a Cary WinUV photometer. Fluorescence studies 
were performed on an SLM AB2 luminescence spectrometer. Fluorescence intensity (steady-
state and time-resolved) were acquired on a Tecan GENios+ micro plate reader. The 
excitation/emission filters were set to 405/612 nm respectively. The decay times of EuTc-
malate were detected with a pulsed 392-nm laser and an H5783-P04 PMT detector with 
multiphoton-counting board in a multipass cuvette. Data were processed wither by FluoFit 
(PicoQuant). Circular dichroism (CD) spectra were acquired on JASCO model J – 710 
spectropolarimeter (www.jasco.de). The 96-well black, transparence, flat bottom microtiter 
plates for imaging were obtained from Greiner Bio-One GmbH. Imaging data were evaluated 
by the IDL software module. 
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Figure 7.1. Scheme of research. 
HP: hydrogen peroxide; EuTc: europium-tetracycline complex; HA: hydroxy acid. 
7. Summary  
The dissertation describes the development of europium-derived fluorescence probes for 
biological substances in aqueous solution. A scheme is shown in Fig. 7.1. Europium-
tetracycline-hydrogen peroxide and europium-tetracycline-hydroxy acid probes have the 
merits of large Stokes´ shift, line-like emission and long lifetime. 
In chapter 1 the mechanism of lanthanide complex luminescence is introduced. The three 
main approaches for time-resolved fluorescence in heterogeneous phase, namely direct 
lanthanide chelate label-based luminescence assay (DLCLLA), dissociation enhanced 
lanthanide fluoroimmunoassay (DELFIA) and enzyme-amplified lanthanide luminescence 
(EALL) are reviewed. 
The time-resolved assay of the activity of peroxidase (POx) by the fluorescent probe 
europium-tetracycline-hydrogen peroxide (EuTc-HP) is presented in chapter 2. At first, the 
catalytic mechanism of POx, as a widely studied enzyme across a range of scientific 
disciplines, is discussed. Quantification is based on the finding that the strongly fluorescent 
complex EuTc-HP (which is in equilibrium with unbound H2O2) is indirectly decomposed by 
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POx to give the weakly fluorescent EuTc following the consumption of H2O2 in MOPS buffer 
at neutral pH. The rate of consumption of the EuTc-HP as monitored via the decrease in 
fluorescence intensity (or change in decay time) is a direct parameter for the activity of the 
POx. The time-resolved assay can detect as little as 1.0× 10-5 Units/ mL of POx, with a 
dynamic range from 4.0 × 10-5 to 5.9 × 10-3 Units/mL. The effects of cyanide, hydroxylamine, 
and azide (all known to inhibit POx) are also studied. 
When POx is exploited as a label and EuTc-HP as a probe, ELISA and oligonucleotide 
hybridization assays can be developed as shown in chapter 3. The time-resolved fluorescent 
assays for biological specimens have advantages over the conventional steady-state assays. 
Two schemes for POx-ELISA, sandwich and direct, have been investigated. The linear range 
is from 0.1 to 8.0 ng/ml for IgG in POx-sandwich ELISA, with 0.1 ng/ml of the limit of 
detection in time-gated method. EuTc-HP also can be used as a reversible molecular sensor 
for the imaging of POx-ELISA. The competitive oligonucleotide hybridization assay by the 
POx label is discussed as well.  
The direct fluorescence detection and imaging of citrate are demonstrated in chapter 4. 
The method is based on the fact that the weakly fluorescent europium-tetracycline (EuTc) 
complex reversibly associates with citrate to form the strongly fluorescent europium-
tetracycline-citrate (EuTc-Cit) complex in HEPES buffer at pH 8.0. Average fluorescence 
lifetime is also increased from 44 µs (for EuTc) to 88 µs (for EuTc-Cit). Steady-state 
fluorometry, TCSPC, time-resolved fluorometry and RLD imaging have been used in citrate 
determination. The time-resolved assay has a dynamic response between 1.6 x 10-7 and 5.6 x 
10-5 M, with a detection limit of 6.0 x 10-8 M for citrate. Compared with other main analytical 
methods for citrate, it is the most sensitive and simplest scheme available up to now. Different 
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tetracycline derivatives are also studied. In addition, this probe is simple to prepare, stable 
both in solution and in solid , and compatible with the blue laser diodes. 
The Krebs cycle, a key series of metabolic reactions in aerobic cellular respiration, is 
occurring in the mitochondria of animals and plants. Fluorescence imaging of main 
intermediates in the Krebs cycle and the some bioprocesses of the intermediates are depicted 
for the first time in chapter 5. Intermediates, i.e. oxaloacetate, citrate, isocitrate, α-
ketoglutarate (KG), succinate, fumarate and L-malate, can reversibly associate with EuTc to 
form EuTc-L complexes having different fluorescent intensities and lifetimes in neutral pH. 
The steady-state fluorescence intensity and rapid lifetime determination imaging have been 
employed in the visualization of the Krebs cycle. The stepwise detection of the formation and 
decomposition of intermediates can be performed via kinetic fluorescence changes. In 
addition, dual fluorescence method, monitoring both NADH and EuTc-L, is exploited. 
Fluorescence chirality sensing is presented in chapter 6. EuTc as a lanthanide chelate is 
employed for the fluorescence discrimination of enantiomeric malates in aqueous solution. 
The fluorescence discriminating ability (FL – F0) / (FD – F0) is 5.9 at 619 nm, which is more 
sensitive than any other chiral fluorometry for α-hydroxy acids reported so far. The average 
lifetimes and quantum yields of EuTc-L-malate and EuTc-D-malate are 84 and 48 µs, 1.7 % 
and 0.7 %, respectively. It is important that this probe can be also applied for the time-
resolved fluorescent determination of the optical purity (ee %) of malate with 120 µs lag time. 
Chiral malates can also be achieved by time-resolved imaging. Other chiral α-hydroxy acids, 
lactate and tartrate are also discussed. It is the first report on using lanthanide ternary 
complexes as a “turn-on” fluorescence chiral molecular sensor. 
Zusammenfassung 
123 
 
 
Abbildung 7.1. Schematische Zusammenfassung der Forschungsarbeit. 
 HP: Wasserstoff-peroxid; EuTc: Europium(III)-tetracyclin; HA: Hydroxysäure. 
8. Zusammenfassung 
Die vorliegende Dissertation zeigt die Entwicklung und praktische Erprobung von 
Europium-Komplexen als Fluoreszenzsonden für biologisch aktive Substanzen in wässriger 
Lösung. Abbildung 7.1 fasst die resultierenden Anwendungsmöglichkeiten zusammen. 
Europium-Tetracyclin geht Komplexverbindungen mit Wasserstoffperoxid oder Hydroxysäu-
ren ein, die sich in ihren optischen Eigenschaften durch eine große Stokesssche Verschiebung, 
eine scharfe Emissionslinie und lange Fluoreszenzabklingzeiten auszeichnen 
Im ersten Teil der Arbeit werden die grundlegenden Eigenschaften und Mechanismen 
der Lumineszenz von Lanthanid-Komplexen erläutert. Im Mittelpunkt stehen dabei die drei 
wichtigsten Methoden zeitaufgelöster Fluoreszenzmessungen in heterogenen Systemen, zum 
einen der „direct lanthanide chelate label-based luminenescence assay“ (DLCLLA) , zum 
anderen der „dissociation enhanced lanthanide fluoroimmunoassay“ (DELFIA), und schließ-
lich die „enzyme-amplified lanthanide luminescence“ (EALL). 
In Kapitel 2 wird ein neuer zeitaufgelöster Fluoreszenztest zur Bestimmung der Aktivität 
von Peroxidase (POx) eingeführt, der auf dem System Europium-Tetracyclin-
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Wasserstoffperoxid (EuTc-HP) als molekulare Sonde basiert. Zunächst wird der Katalyse-
mechanismus von POx beschrieben, einem Enzym, das in der wissenschaftlichen Forschung 
bereits eingehend untersucht wurde. Die Quantifizierung der Enzymaktivität erfolgt über den 
indirekten Abbau des stark fluoreszierenden EuTc-HP-Komplexes. Dieser steht im Gleichge-
wicht mit ungebundenen H2O2  in der gepufferten Lösung, das durch den enzymatischen Ein-
fluss von POx umgewandelt wird. Die Umsatzrate von EuTc-HP kann als direkter Parameter 
für die Enzymaktivität durch die Abnahme der Fluoreszenzintensität oder Veränderungen in 
der Fluoreszenzabklingzeit detektiert werden. Der zeitlich aufgelöste Fluoreszenztest hat eine 
Nachweisgrenze von 1 x 10-5 U/mL POx  mit einem dynamischen Messbereich von 4.0 x 10-5 
bis 5,9 x 10-3 U/mL. Der Einfluss von Inhibitoren wie Cyanid, Hydroxylamin und Azid auf 
die Aktivität von POx wurde ebenfalls untersucht. 
Wird POx als Biomarker und EuTc-HP als molekulare Sonde eingesetzt, können 
ELISAs und DNA-Hybridisierungsassays detektiert werden. Kapitel 3 verdeutlicht, dass 
zeitaufgelöste Fluoreszenztests für Biomoleküle den gebräuchlichen Intensitätsmessungen 
überlegen sind. Ein Sandwich- und ein direkter POx-ELISA wurden im Rahmen dieses 
Projekts untersucht. Dabei wurde ein linearer Messbereich für IgG von 0,1 bis 8.0 ng/ml mit 
einer Nachweisgrenze von 0,1 ng/ml  erhalten. EuTc-HP kann auch als reversibler molekula-
rer Sensor für das Imaging von POx-ELISAs verwendet werden. Ein kompetitiver Hybridisie-
rungstest für Oligonukleotide mit Hilfe von POx-Markern wird ebenfalls diskutiert.  
Ein direkter Fluoreszenznachweis auf Citrat, einem in der Natur allgegenwärtigen Stoff, 
mittels bildgebender Verfahren wird in Kapitel 4 entwickelt. Die Methode basiert auf der 
Fähigkeit des schwach fluoreszierenden Europium-Tetracyclins reversibel Citrat zu binden 
und dabei einen stark fluoreszierenden Europium-Tetracyclin-Citrat-Komplex (EuTc-Cit) zu 
bilden. Die mittlere Fluoreszenzlebensdauer wird in Folge ebenfalls  von 44 µs (EuTc) auf 88 
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µs (EuTc-Cit) erhöht. Stationäre Fluorometrie, TCSPC, zeitaufgelöste Fluorometrie und RLD 
Imaging können so zur Bestimmung von Citrat herangezogen werden. Der zeitauf-gelöste 
Fluoreszenztest ergibt einen dynamischen Messbereich von 1,6 x 10-7 bis 5,6 x 10-5 M bei 
einer Nachweisgrenze von 6.0 x 10-8 M Citrat. Verglichen mit anderen Bestimmungs-
methoden für Citrat ist dies momentan das empfindlichste und einfachste verfügbare 
analytische Verfahren. Darüber hinaus ist dieser molekulare Sensor einfach zu synthetisieren, 
stabil sowohl in gelöster als auch in fester Form und kompatibel zur Anregungswellenlänge 
eines blauen Diodenlasers. Die Eigenschaften anderer Tetracyclin-Derivate wurden ebenfalls 
untersucht. 
Der Citrat (Krebs)-Zyklus ist ein essentieller Bestandteil des aeroben Zellstoffwech-sels 
und findet in den Mitochondrien von tierischen und pflanzlichen Zellen statt. Das Fluo-
reszenz-Imaging der wichtigsten Zwischenprodukte des Citrat-Zyklus steht im Mittelpunkt 
von Kapitel 5. Diese Zwischenprodukte wie Oxalacetat, Citrat, Isocitrat, α−Ketoglutarat, 
Succinat, Fumarat und L-Malat können reversibel an EuTc als weiterer Ligand (L) gebunden 
werden. Die resultierenden EuTc-L-Komplexe weisen unterschiedliche Fluoreszenzintensitä-
ten und Abklingzeiten auf. Die Aufnahme der stationären Fluoreszenzintensität einerseits und 
RLD Imaging andererseits wurden zur Visualisierung dieser Verbindungen eingesetzt. Die   
Bildung und der Verbrauch der verschiedenen Zwischenstufen kann mit Hilfe kinetischer 
Fluoreszenzmessungen schrittweise detektiert werden. Zusätzlich kann mit einer dualen 
Fluoreszenzmethode die Änderung des Gehalts von NADH und EuTc-L gleichzeitig über-
wacht werden.  
Schließlich werden in Kapitel 6 chirale Fluoreszenzsensoren beschrieben. EuTc kann zur 
Unterscheidung der beiden enantiomeren Formen von Malat in wässriger Lösung benutzt 
werden. Der Unterschied in der Fluoreszenzintensität nach der Koordination beider Isomerer 
Zusammenfassung 
126 
(FL-F0) / (FD-F0) beträgt 5,9 bei einer Emissionswellenlänge von 619 nm. Das ist ein höherer 
Faktor als bei allen anderen bekannten chiralen fluorimetrischen Verfahren für α-Hydroxy-
säuren. Die mittleren Fluoreszenzabklingzeiten von EuTc-L-Malat und EuTc-D-Malat 
betragen 84 bzw. 48 µs, die Quantenausbeuten 1,7 % bzw. 0,7 %. Die enantiomeren Formen 
von Malat können auch mittels zeitaufgelöstem Fluoreszenzimaging angezeigt werden. 
Weitere chirale α-Hydroxysäuren, sowie Laktat und Tartrat werden ebenso diskutiert. Somit 
ist diese die erste Arbeit, bei der ternäre Lanthanid-Komplexe als „einschaltbare“ molekulare 
chirale Fluoreszenzsensoren eingesetzt werden. 
 
 
* Please notice that the German summary is just for your information. For the details, please 
check the English version.  
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